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Post-translational modification of cysteine residues can regulate protein
function and is essential for catalysis by cysteine-dependent enzymes. Covalent
modifications neutralize charge on the reactive cysteine thiolate anion and thus
alter the active site electrostatic environment. Although a vast number of enzymes
rely on cysteine modification for function, precisely how altered structural and
electrostatic states of cysteine affect protein dynamics, which in turn, affects
catalysis, remains poorly understood.
Here we use X-ray crystallography, computer simulations, site directed
mutagenesis and enzyme kinetics to characterize how covalent modification of the
active site cysteine residue in the enzyme, isocyanide hydratase (ICH), affects the
protein conformational ensemble during catalysis. Our results suggest that
cysteine modification may be a common and likely underreported means for
regulating protein conformational dynamics. This thesis will also include ongoing
work with ICH homologs, showing that Cys covalent modification-gated helical
dynamics in Cys dependent enzymes is common to enzymes of this family.
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Table 1: Pseudomonas ICH Enzyme kinetic parameters
*measured at 160 μM p-NPIC and [enzyme]=50 nM.
Standard deviations are derived from the fit; data measured n≥3

PfICH Enzyme
Steady State Kinetics
kcat (sec-1)
KM (μM)
kcat/KM (M-1 sec-1)
Stopped Flow mixing
Burst rate constant (sec-1)*
Second order rate constant for
burst (M-1 sec-1)
Steady state rate kobs (sec-1)*

WT

G150A

G150T

0.248±0.031
9.262±3.250
2.68x104

0.025±0.002
1.208 ±0.6134
2.07x104

0.046±0.003
8.892±1.529
5.21x103

11.395±0.120
4.85x104±943

11.882±0.071
5.51x104±557

4.255±0.187
1.11x104±999

0.268±0.001

0.046±0.002

0.095±0.003

x

Table 2: Pseudomonas ICH Crystallographic Data Statistics
Values for the highest resolution bins are shown in parenthesis
WT ICH
RT1
(less
oxidized)

WT ICH
RT1 (more
oxidized)

G150A
ICH

G150T
ICH

WT ICH
XFEL:
Apo1

WT ICH
XFEL: 5
min1

WT ICH
cryo

LCLS
MFX

WT ICH
XFEL: 15
sec
Thioimida
te1
LCLS
MFX

Diffraction
source

SSRL
12-2

SSRL
7-1

SSRL
12-2

SSRL
7-1

LCLS
MFX

APS
14BM-C

Wavelength
(Å)

0.827

0.975

0.827

0.975

1.305

1.305

1.305

0.900

Temperature
(K)

274

277

274

277

298

298

298

100

Detector

Pilatus 6M

ADSC
Q315

Pilatus 6M

ADSC
Q315

P21

P21

P21

C2

Rayonix
MX170HS
P21

Rayonix
MX170HS
P21

Rayonix
MX170HS
P21

Space group
a, b, c (Å)

57.24
58.03
69.09

57.15
57.97
69.09

57.04
57.90
69.11

72.11
59.74
56.13

56.88
57.68
68.78

56.77
57.42
68.79

56.81
57.64
68.76

56.58
56.47
68.23

α, β, γ (°)

90.00
112.83
90.00

90.00
112.77
90.00

90.00
112.55
90.00

90.00
115.86
90.00

90.00
112.74
90.00

90.00
112.74
90.00

90.00
112.74
90.00

90.00
112.49
90.00

Mosaicity (°)

0.08

0.08

0.08

0.07

N/A5

N/A5

N/A5

0.27

Resolution
range (Å)

39.04-1.20
(1.22-1.20)

42.87-1.15
(1.17-1.15)

38.96-1.30
(1.32-1.30)

35.45-1.10
(1.12-1.10)

20.13-1.55
(1.57-1.55)

20.09-1.55
(1.57-1.55)

20.1-1.55
(1.57-1.55)

37-1.05
(1.09-1.05)

Total no. of
observations

363112
(16358)

517060
(15585)

327591
(13542)

224032
(2017)

3032726
(18818)

3185312
(16342)

2648001
(38049)

1077211
(79769)

No. of unique
observations

126373
(5922)

145885
(6657)

100249
(4568)

84423
(1216)

60075
(2983)

60053
(2970)

60082
(2988)

179423
(17341)

Completeness
(%)

97.4 (92.7)

98.9 (91.2)

98.1 (90.1)

97.2 (95.9)

99.9 (99.8)

99.9 (99.4)

99.9 (100)

97.1 (94.2)

Multiplicity

2.9 (2.8)

3.5 (2.3)

3.3 (3.0)

2.7 (2.0)

50.5 (6.3)

53.0 (5.5)

44.1 (12.7)

6.0 (4.6)

〈I/σ(I)〉

10.4(1.8)

12.5 (0.8)

9.1 (1.2)

9.7 (1.4)

60.5 (2.0)

58.4 (1.8)

73.1 (3.4)

22.8 (2.1)

CC1/22

0.991
(0.225)

0.999
(0.488)

0.996
(0.318)

0.999
(0.690)

0.962
(0.16)

0.963
(0.14)

0.937
(0.36)

N/A4

Rmeas (Rsplit for
XFEL data)3

0.072
(1.689)

0.059
(0.959)

0.066
(1.513)

0.045
(0.545)

0.196
(0.862)

0.197
(0.905)

0.232
(0.658)

0.07 (0.70)

Sample

1

RT, Room temperature synchrotron radiation collection; XFEL, X-ray free electron laser
CC1/2 (31) was used to determine the high resolution cutoff.
3
Rsplit is provided only for XFEL serial crystallographic data
4
Dataset from PDB 3NON, processed before the introduction of CC 1/2
5
N/A=not applicable for serial crystallographic data
2

ADSC
Q315
P21

xi

Table 3: Pseudomonas ICH Crystallographic Refinement Statistics
WT ICH
RT1 (less
oxidized)

WT ICH
RT1
(more
oxidized)

G150A
ICH

G150T
ICH

WT
ICH
XFEL:
Apo1

WT ICH
XFEL:
15 sec
Thioimid
ate1

WT ICH
XFEL: 5
min1

WT ICH
RT1 (less
oxidized)
qFit
model

PDB code
Temperature (K)
Refinement
program
Resolution range
(Å)
Completeness (%)

6NI6
274
PHENIX
1.9
31.841.20
95.17

6NI7
277
PHENIX
1.9
38.531.15
98.87

6NI5
274
PHENI
X 1.9
33.561.30
97.83

6NI4
277
PHENI
X 1.9
35.141.10
97.16

6NPQ
298
PHENI
X 1.9
20.131.55
99.93

6UND
298
PHENIX
1.9
20.091.55
99.86

6UNF
298
PHENIX
1.9
17.461.55
99.96

6NI9
274
PHENIX
1.9
31.841.20
95.00

WT
ICH
cryo
with
helix
disorde
r
6NJA
100
PHENI
X 1.9
37.821.05
97.11

No. of reflections

123572

145829

99966

84275

59628

59214

59498

123572

179399

No. of reflections,
test set

6203

7300

4970

4186

2002

1986

1995

6203

8979

0.1140
(0.2281)
0.1398
(0.2611)

0.1128
(0.2633)
0.1353
(0.2607)

0.1192
(0.2745)
0.1519
(0.3159)

0.1098
(0.2294)
0.1283
(0.2332)

0.1560
(0.3075)
0.1864
(0.3244)

0.1636
(0.3244)
0.1906
(0.3177)

0.1727
(0.2777)
0.1918
(0.2836)

0.1078
(0.2207)
0.1402
(0.2628)

0.1170
(0.2105)
0.1342
(0.2487)

4446
323
4769

4892
323
5215

1868
149
2017

3475
298
3773

3449
271
3720

3500
272
3772

6192
382
6574

4551
484
5035

0.008
1.020

0.014
1.290

0.011
1.376

0.007
0.850

0.004
0.729

0.005
0.801

0.011
1.399

0.009
1.111

19.57

21.12

17.21

24.18

24.97

25.78

15.92

11.91

37.40

39.73

31.30

38.83

38.61

44.80

36.74

26.43

0.481
0.415

0.400
0.353

0.502
0.439

0.599
1

0.553
1

0.626
1

0.394
0.354

0.407
0.408

2.2

4.1

0.8

2.0

1.6

1.3

2.4

3.2

0.3
1.4
98.3

0.5
2.0
97.5

0.0
1.2
98.8

0.4
1.3
98.2

0.4
1.3
98.2

0.4
1.8
97.8

0.3
1.1
98.6

0.3
1.9
97.8

Model

Rwork
Rfree

No. of non-H atoms
Protein
4486
Water
342
Total
4828
Average R.M.S. deviations
Bonds (Å)
0.007
Angles (°)
0.909
Average B factors (<Biso>;Å2)
Protein
17.34
Water

36.77

Average ADP anisotropy2
Protein
0.396
Water
0.327
MolProbity
1.1
clashscore
Ramachandran plot
Outliers (%)
0.5
Allowed (%)
1.4
Favored (%)
98.1

Values for the highest resoltions bin shown in parenthesis
1
RT, Room temperature synchrotron radiation collection; XFEL, X-ray free electron laser
2
Anisotropy is defined as the ratio of the smallest to largest eigenvalue of the ADP tensor

xii

Table 4: Ralstonia ICH Enzyme kinetic parameters
Standard deviations are derived from the fit; data measured n≥3

RsICH Enzyme
Steady State Kinetics
kcat (sec-1)
KM (μM)
kcat/KM (μM-1 sec-1)
Stopped Flow mixing*
Pre steady state rate
constant (sec 1)

WTRsICH

E122D

E122Q

E122T

75.65
116.9
0.65

0.15
1.28
0.12

0.37
6.79
0.05

0.34
27.59
0.01

0.11274

*measured at 80 μM p-NPIC

11.882±0.071

4.255±0.187

0.16851

xiii

Table 5: Ralstonia ICH Crystallographic Refinement Statistics
Data collected at University of Nebraska Macromolecular Structural Core Facility
Model

WT RsICH
(plate)

WT
RsICH
(rod)

WT RsICH
(tetragonal)

E122T
(plate)

E122D
(plate)

PDB code
Temperature (K)
Detector

NA
110
Raxis IV++

NA
110
Raxis IV++

Refmac5
(CCP4)
40.21-1.50
100.0

94.7

100.0

NA
110
Raxis
IV++
Refmac5
(CCP4)
38.421.46
96.0

NA
110
Raxis IV++

Refinement
program
Resolution range
(Å)
Completeness
(%)(overall)
Space Group

NA
110
Raxis
IV++
Refmac5
(CCP4)
38.52-1.46

P 21 21 21

P 21 21 21

P 41 21 2

P 21 21 21

a, b, c (Å)

47.84
89.17
93.04
90.00
90.00
90.00
11.0 (1.1)

48.13
89.04
92.77
90.00
90.00
90.00
13.6 (3.5)

63.50
63.50
121.46
90.00
90.00
90.00
21.0 (4.3)

0.997
(0.581)
65123

0.995
(0.891)
65535

0.999
(0.97)
31929

P 21 21
21
47.90
89.19
92.88
90.00
90.00
90.00
26.8
(4.7)
0.998
(.949)
66459

362961

341308

394901

888305

817104

0.1975

0.1812

0.2002

0.1931

0.19308

Rmerge

0.73
(0.926)

0.66
(0.302)

0.62
(0.308)

.057
(0.528)

.066 (0.34)

MolProbity
clashscore
Ramachandran
Favored (%)
Ramachandran
Outliers (%)

2.45

2.25

2.82

2.84

4.75

97.95

97.95

96.8

97.72

97.49

0.46

0.91

1.37

0.68

1.14

α, β, γ (°)

〈I/σ(I)〉
CC1/2 (overall)

No. of unique
observations
No. of
observations
(overall)
Rfree

Refmac5
(CCP4)
44.9-1.63

Refmac5
(CCP4)
33.46-1.46
99.5

48.20
89.20
92.96
90.00
90.00
90.00
22.5 (5.5)
0..999
(0.952)
69583

xiv

Table 6: Ralstonia ICH Crystallographic Refinement Statistics
Data collected at SSRL beamline 12-2 from single crystal with 0.2°/ image and 0.15 sec/image
Model

WT RsICH

E122D

E122Q

E122T

PDB code
Temperature
(K)
Detector

NA
100K

NA
100K

NA
100K

NA
100K

Pilatus 6M Pixel
Array Detector
(PAD)

Pilatus 6M Pixel
Array Detector
(PAD)

Pilatus 6M Pixel
Array Detector
(PAD)

Pilatus 6M Pixel
Array Detector
(PAD)

0.729

0.729

0.729

96%

96%

96%

96%

Refinement
program
Resolution
range (Å)
Completenes
s
(%)(overall)
Space Group

XDS, Aimless,
CCP4 (Refmac 5)
38.58 (0.74)

XDS, Aimless,
CCP4 (Refmac 5)
38.6 (0.82)

XDS, Aimless,
CCP4 (Refmac 5)
*

XDS, Aimless,
CCP4 (Refmac 5)
38.51 (0.95)

98.0 (89.5)

99.8 (97.4)

*

99.8 (98.7)

P 21 21 21

P 21 21 21

P 21 21 21

P 21 21 21

a, b, c (Å)

48.23, 89.15, 92.81

48.22, 89.2, 93.01

*

48.03, 89.39, 92.93

α, β, γ (°)

90.00 90.00 90.00

90.00 90.00 90.00

90.00 90.00 90.00

90.00 90.00 90.00

19.7 (0.9)

20.1 (1)

*

14.6 (1.2)

1.0 (0.322)

1.0 (0.346)

*

0.999 (0.492)

Mosaicity

0.06

0.09

*

0.05

No. of
unique
observations
No. of
observations
(overall)
Rfree

517136

389097

*

250613

3554784

3315656

*

2754808

0.1259

0.1155

*

0.13364

Wavelength
(Å)
Attenuation
(%)

〈I/σ(I)〉
CC1/2 (overall)

0.729

Values for the highest resolution bin shown in parenthesis
*pending refinement
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Chapter 1: Introduction
Isocyanides as natural products
Isocyanides, also referred to as isonitriles or carbylamines, are isomers of
cyanides (-C≡N). Isocyanide is the IUPAC approved nomenclature for these compounds,
although the word “isonitriles” is still widely used, but not preferred. Isocyanides
possess the functional group N≡C, with the organic moiety connected to the isocyano
group (N≡C) via the N atom. The discovery of this unusual class of compounds was an
accident; in 1859 Lieke 1 reacted allyl iodide with silver cyanide, intending to produce
cyanide, but instead, ended up with a foul-smelling compound that converted to formic
acid upon acid hydrolysis2. This particularly vile smelling product was recognized as a
member of a new class of compounds, termed “Isomeric to Nitrile”, or “Isonitrile”3. The
newly discovered isocyanides were unique in that they were the only stable organic
entities whose carbon was bonded to a single atom.

Fig. 1: Zwitterionic and carbene
representations of the isocyano group.

Isocyanides are highly reactive; the carbon atom of the isocyano group possesses both
electrophilic as well as nucleophilic character. This makes isocyanides ideal for synthetic
applications4, such as multicomponent condensation reactions5,6,7, carbohydrate and coordination chemistry8,9,10, addition reactions11,12 etc. Several studies have been performed
to understand their electronic and geometric structures in order to explain their dual
electrophilic and nucleophilic characters. For a while, the two most widely accepted
forms of isocyanides were the carbenic form 13 and the zwitterionic form14 (Fig. 1).

2

These, however, are not without their individual caveats; the carbenic form was not
consistent with the dipole moment and the IR- C-N stretching band at 2130 cm-115,
whereas the zwitterionic form could not explain the electrophilic character of
isocyanides. This structural disparity was finally addressed by performing Valence bond
calculations, which supported a predominantly carbenic structure for isocyanides, with
the zwitterionic resonance form being a secondary contributor. The unusual isocyano
group allows isocyanides to function as biologically active naturally derived compounds
such as chelators of transition metals, antibiotics, antiviral agents, marine sponge derived
metabolites etc16.
In 1948, Rothe 17 isolated the first naturally occurring isocyanide, Xanthocillin,
from the fungus Penicillium notatum. Xanthocillin was structurally characterized by
Hagedorn and Tonjes 18,19 in 1957, almost 100 years after Lieke’s “accidental” chemical
synthesis of the first allyl isocyanides. The first marine-type isocyanide to be isolated was
axisonitrile-1, from the marine sponge Axinella cannabina 20. Since then, a multitude of
isocyanides and related compounds have been isolated from both marine and non-marine
sources. The division of isocyanide natural products into terrestrial and marine clades has
its roots in the history of their discovery as well as differences in their biosynthetic
precursors, where known. This thesis will adhere to this overarching classification
scheme for isocyanide natural products, although we note that other chemical taxonomies
for these compounds are possible and perhaps desirable. Here, we will cover the
biochemistry of isocyanide natural products, including their biological targets,
biosynthetic and degradative pathways in marine vs non-marine sources as well as
identifying areas where open questions invite future inquiry.

3

1.1.1 Terrestrial isocyanides: Many isocyanides have been isolated from non-marine
microbial sources. Terrestrial isocyanides can be classified into three primary classes
based on their structures: xanthocillins, cyclopentyls and assorted others 2,19.
1.1.1.a Biosynthesis of terrestrial isocyanides: Isocyanides are naturally produced in
certain microbes as secondary metabolites. Remarkably, fundamental questions remain
about the installation of the isocyanide moiety, including the still-unknown mechanisms
of most validated isocyanide biosynthetic enzymes.
Isocyanides, as mentioned previously, possess a unique functional group and are
naturally produced in certain microbes as secondary metabolites. Because of their value
as bioactive natural products, there is significant interest in delineating the biosynthetic
mechanisms of this unusual class of compounds. The primary difference between the
biosynthetic origins of marine vs non-marine isocyanides is that the former are derived
from terpenoids while terrestrial isocyanides are mostly derived from amino acids19. Most
of the backbone of these terrestrial isocyanides (the xanthocillins, the cyclopentanes and
others), as well as the nitrogen atoms in the isocyanide group, originate primarily from
tyrosine 21–28. However, the origin of the carbon atom of the isocyanide group remained a
mystery for some time. Puar et al 21 attempted to address this issue by synthesizing
hazimicins from cultures of Micrococcus luteus that were fed 14C-labelled precursors;
their findings indicate that the isocyanide carbon in hazimicins originates from
methionine 21–23,29. Investigations into the source of the isocyanide carbon atoms of
Xanthocillin X monomethyl ether (XME) in glucose-starved cultures of fungus
Dichotomomyces cejpii via [U-13C] glucose feeding experiments revealed that the
isocyanide carbon atoms were derived from glucose metabolism rather than pathways
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involving tetrahydrofolate metabolism such as methionine, glycine, serine, TCA cycle,
cyanides, cyanates or carbamoyl phosphate22,29.

Fig. 2: Biosynthesis of isocyanides and origin of the isocyano group; the carbon atom of the isocyano
group comes from ribulose-5-phosphate, the nitrogen atom can originate from tryptophan (A) or tyrosine
(B). Chemical structures constructed using ChemDraw (Perkin Elmer).

The specific precursor of the isocyanide carbon remained unknown still. Interestingly,
Penicillium notatum produces a di formamide compound, which appears in the culture
before Xanthocillin and, which when added to the fungal culture, boosts the production
of Xanthocillin X2,30. This suggests that formamides might be the precursors of
isocyanides via dehydration reactions. This notion is debatable, as the discovery of the
enzyme isocyanide hydratase (ICH) shows that formamides can the metabolic products of
isocyanide, rather than precursors. ICH hydrates the isocyano groups in isocyanides to
synthesize the corresponding formamides, which are then degraded to the corresponding
amines and formates31–33. Therefore, formamide is one product of isocyanide degradation
rather than a synthetic precursor, although not all biosynthetic routes to isocyanides are
known.
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Clardy et al 34 made significant headway into solving the mystery of the origin of
the carbon atom of the isocyanide group when they developed a novel approach of
cloning and heterologous expression of eDNA. eDNA is DNA from environmental
samples (uncultured soil bacterium) that can be transformed into easily cultured lab
bacteria, permitting the identification and characterization of antibiotics from
“antibacterially active eDNA clones using a high-throughput phenotypic screen”. They
isolated an eDNA clone, CSLG18, which produces an indole-based isocyanide in E. Coli
and identified its biosynthetic genes, isocyanide synthase (IsnA) and ɑ ketoglutaratedependent oxygenase (IsnB) (Fig. 2). They observed that all the nitrogen atoms in this
novel isocyanide are derived from the amino acid tryptophan. The source of the carbon
atom of the isocyanide was identified as the C2 atom of Ribulose-5-phosphate 35. The
biosynthetic reaction proceeds via attachment of the carbonyl carbon of ribulose-5phosphate to the ɑ amine of L-Tryptophan, catalyzed by isocyanide synthase (IsnA). The
resulting intermediate is then resolved to the isocyanide product by hydroxylation and
decarboxylative desaturation by the oxygenase (IsnB) (Fig. 2). 34–36. During this process,
the carbonyl carbon of ribulose-5-phosphate undergoes a 2-electron oxidation to become
the isocyanide carbon atom, catalyzed by IsnA and B acting co-operatively 36.
1.1.1.b Identification of IsnA/B homolog gene clusters: The identification of
biosynthetic genes and a biosynthetic pathway of an isocyanide was an important
discovery. This opened the door to a large number of isocyanide biosynthetic studies
involving IsnA/B homologs when a BLAST search of sequenced bacterial genomes
revealed several IsnA homolog operons 37. One class of isocyanide natural products
whose biosynthesis was clarified by the discovery of IsnA/B is the hapalindoles.
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Hapalindoles are terpenoid indole-containing bioactive alkaloids produced by
cyanobacteria belonging to the order of Stigonemataceae (Fischerella sp. and
Hapalosiphon sp.); these compounds are divided into several classes, including the
welwitindolelinones 38,39 and

Fig. 3: The PvcABCD operon in
Pseudomonas aeruginosa synthesizes
the isocyanide metabolite,
Paerucumarin and its corresponding
hydration product, Pseudoverdine from
Tyrosine and Ribulose-5-phosphate.
Paerucumarin signals the upregulation
of biofilm development gene cluster
cupB/C in pathogenic P. aeruginosa
either by directly targeting the histidine
kinases RocS1 and S2 or indirectly by
activating an undetermined
transcriptional activator “Y”. RocS1
and RocS2 signaling results in
activation of cupC/B genes. Chemical
structures constructed using
ChemDraw (Perkin Elmer).
.

40,41

ambiguines

(Fig. 6). (covered in more detail below). Investigations into the

biosynthetic genes for these isocyanide hapalindoles revealed a 42Kbp ambiguine (amb)
biosynthetic gene cluster in cyanobacterium Fischerella ambigua UTEX1903. This
cluster encode the enzymes AmbI1-3, responsible for the isocyanide group assembly 39.
Interestingly, AmbI1-3 are close homologs of IsnA/B (46% identity), with AmbI1-2
sharing homology with IsnA and AmbI3 with IsnB. AmbI1-2 can functionally
complement IsnA in vitro, converting L-tryptophan and ribulose-5-phosphate into the
same intermediate as in Fig. 2. This intermediate is then resolved by AmbI3 into Z-3-(2-
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isocyanovinyl)-1 H indole, instead of the isomeric E-3-(2-isocyanovinyl)-1 H indole
synthesized when the intermediate is resolved by IsnB 36. This indicates that IsnB is
specific to the E isomer while AmbI3 is specific to the S form (Fig. 2). Investigations into
the biosynthetic genes for welwitindolinone-type isocyanides revealed a 36Kbp gene
cluster in Hapalosiphon welwitschii UTEX B183042 containing the proteins WelI1,2,3
which are close homologs of AmbI1,2,3 from the amb operon. Whether WelI1,2,3
proteins can attach the nitrogen atom from L-tryptophan with the carbonyl carbon from
ribulose-5-phosphate to generate a vinyl isocyanide, as done by AmbI1,2,3, remains
untested.
Other homologs of IsnA/B include PvcA/B; IsnA has a 33% sequence identity
with pvcA which is involved in C-N bond formation34,43. IsnB shows sequence similarity
to non-heme Fe2+ ɑ-ketoglutarate-dependent oxygenases, including pvcB 44. The PvcA
and B genes are a part of the Pvc gene cluster, which is a four gene (Pvc A, B, C, D)
operon in Pseudomonas aeruginosa. P. aeruginosa is a human pathogen and its in vivo
growth and pathogenesis are promoted by the synthesis of two siderophores, pyoverdine
and pyochelin43. Initially the Pvc gene cluster was implicated in the synthesis of the
pyoverdine chromophore, hence the name of the operon, but later this claim was refuted
as the major product of this operon is a cyclized tyrosine derived isocyanide containing
cumarin, paerucumarin (2-isocyano-6,7-dihydroxycoumarate) 44,45. The biosynthetic
reaction was proposed by Brady and Clarke-Pearson45 (Fig. 3). The pvc genes were also
shown to be involved in the synthesis of pseudoverdine, a pyoverdine-related fluorescent
bicyclic compound. Paerucumarin is an unstable compound and can easily decompose
into pseudoverdine by hydration (the isocyanide group is simply replaced by N-formyl

8

group in pseudoverdine) 46. Interestingly, the Pvc gene cluster is negatively regulated by
the presence of iron. Under conditions of iron limitation, the Pvc operon is upregulated to
either synthesize the siderophore pyoverdine in certain strains of Pseudomonas, or to
synthesize paerucumarin and pseudoverdine, which are potentially siderophores.
Moreover, the Pvc gene cluster in P. aeruginosa is positively regulated by the LysR
family transcription factor PtxR 45, which also upregulates the expression of the toxA
gene encoding exotoxin A under conditions of iron limitation47. In addition, PtxR
regulates the expression of other virulence factor genes that promote quorum sensing in
P. aeruginosa48. However, the role of the Pvc gene cluster in promoting P. aeruginosa
pathogenicity remains unexplored. Moreover, PvcA and B homologs are found in a large
number of human, insect and plant pathogenic microbes, such as, Legionella
pneumophila, Vibrio cholerae, Burkholderia mallei, Photorhabdus luminescens,
Xenorhabdus nematiphila, Erwinia carotovora, Bdellovibrio bacteriovirus, etc. 45.
Legionella pneumophila, the causative agent of Legionnaire’s disease, is an
infectious bacterium that possesses a five gene biosynthetic gene cluster (BGC)
containing homologs of isnA and B named lpg0174 and lpg0175 49. Moreover, this gene
cluster is upregulated during the growth of the bacteria in human host macrophages,
which suggests its potential role in virulence, possibly as siderophores to promote iron
uptake by the pathogen. The BGC operon encodes four novel N-acyl-L-histidines
(primarily by the lpg0178 gene), consistent with the observation 50 that L-histidine
biosynthesis in upregulated during the growth of the pathogen within human
macrophages.
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E. coli cells expressing the Legionella BGC operon (lpg0173-177) were capable
of synthesizing the isocyanide rhabduscin (Fig. 2) 49 51, although rhabducin was not
detected in wild type Legionella cells. Possible explanations for this are that rhabducin is
unstable and rapidly converted to some other untraceable metabolite or that other
experimental conditions are required for expression of the BGC biosynthetic operon.
Rhabduscin is also produced by the insect pathogens Xenorhabdus nematophila and
Photorhabdus luminescens. The Xenorhabdus nematophila ATCC19061 genome
contains a rhabduscin biosynthetic gene cluster comprising the IsnA and B homologs
XNC1_1221 and XNC1_1222 as well as a glycosyltransferase gene (XNC1_1223) 51,
similar to a biosynthetic gene cluster in Photorhabdus luminescens TT01 51.
Heterologous expression of the rhabduscin biosynthetic transgenes in E. coli resulted in
the synthesis of the minor isocyanide functionalized glycoside, byelyankacin, and
rhabduscin, although the latter could not be detected in most cases owing to sensitivity of
the isocyanide group to hydrolysis to yield formamide derivatives. It would be interesting
to know if hydrolysis of the isocyanide group in rhabduscin in E. coli is controlled by a
Pseudomonas ICH homolog enzyme.
Byelyankacin, or E-4-(2-isocyanivinyl) phenyl ɑ-L-rhamnopyranoside, was first
isolated from Enterobacter sp, and was shown to be an inhibitor of phenoloxidase-type
enzyme tyrosinase and melanin synthesis in humans51,52. This, along with the observation
that isocyanides are produced by a large number of pathogens, has directed attention
towards the potential role of Rhabduscin, and other isocyanide natural products, in the
suppression of host innate immunity.
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Fig. 4. Role of (left) ScoB-E
(Actinomycetes sp) and
(right) MmaB-E
(Mycobacterium marinum)
in INLP1-2 biosynthesis.
.

In addition to the discussed mechanism of biosynthesis of isocyanides involving IsnA
and B and their homologs, another mechanism was proposed involving a biosynthetic
gene cluster in Mycobacterium. Mycobacterium tuberculosis, the causative agent for
tuberculosis, contains a biosynthetic operon, Rv0096-0101, encoding five enzymes
conserved across pathogenic mycobacterium as well as Streptomyces, Nocardia,
Rhodococcus etc. These enzymes are an iron(II) and α-ketoglutarate (α-KG)- dependent
oxidase, fatty acyl-CoA thioesterase, acyl-acyl carrier protein ligase (AAL), acyl carrier
protein (ACP) and non ribosomal peptide synthase. Co-expression of these genes from
Mycobacterium marinum (mma-E) and Streptomyces coeruleorubidus (scoA-E), in E.
coli resulted in the synthesis of two isocyanide-functionalized lipopeptides (INLP 1 and
2). INLP1 and INLP2 are structurally similar to two known isocyanide antibiotics
(SF2768 and SF2369) from Actinomycetes sp 53. Investigation into the biosynthetic
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mechanism revealed a multistep process (Fig. 4), starting with the adenylation of crotonic
acid by ScoC, which is then transferred to an acyl carrier protein (ScoB); a lyase (ScoD)
attaches a glycine to the β position of the ɑ, β unsaturated fatty acyl-ACP which then
undergoes oxidation and dephosphorylation by the oxidase (ScoE) to form the isocyanide
group. A similar biosynthetic mechanism exists in M. marinum with MmaC that favors
longer chained fatty acid substrates, in contrast with ScoC53(Fig. 4).
The previously mentioned di-isocyanide antibiotic SF2768, is produced by the
Actinomycetes Streptomyces thioluteus, which contains an isocyanide biosynthetic
operon (sfa) encoding a dioxygenase (SfaA), an AMP ligase (SfaB), a peptidyl carrier
protein (SfaC), a nonribosomal protein synthetase (SfaD) and a hydroxylase (SfaE) 54
(Fig. 5). Interestingly, production of this di-isocyanide is often accompanied by mixed
isocyanide-formamides and even di-formamides; this led to the discovery of another gene
in the sfa operon, SfaF that encodes an isocyanide hydratase. Isocyanide hydratase adds
water to the isocyano groups to yield formamides (SfaF has a 32% sequence identity to
InhA, encoding the first characterized isocyanide hydratase from Pseudomonas putida.
32,55

.
The identification of so many isocyanide synthase (IsnA/B) homologs in

sequenced bacterial genomes suggests the possibility that several more isocyanide
biosynthetic gene clusters reside in the genomes of uncultured bacteria. A total of 12
IsnA containing biosynthetic gene clusters were identified and isolated from
approximately 400,000 screened eDNA cosmid clones. Some of these operons contained
simply the IsnA and B domains, while others were more complex and contained
additional genes encoding biosynthetic enzymes 37. The gene clusters were amplified and
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expressed in E. coIi or Pseudomonas aeruginosa to identify the clone-specific
metabolites, 4 of which were shown to contain isocyanide groups 37. Importantly, one of
these four isocyanides is Paerucumarin, a previously described isocyanide natural product
(Fig. 3).
The first isocyanide biosynthetic pathway in a fungus, Aspergillus fumigatus, was
identified very recently56. The genome of Aspergillus fumigatus AF293 contains four
isocyanide synthases (ICS), namely, CrmA, IcsA, IcsB and XanB, spread between three
biosynthetic gene clusters (ICS3G, ICS4G and ICS5G). Under conditions of copper
limitation, the ICS5G gene cluster containing the isocyanide synthase XanB produces
four Xanthocillin derived isocyanides in A. fumigatus: a diformamide, a fumiformamide,
BU 4704, and Xanthocillin monomethyl ether (XME)56 (Fig. 6). Inspection of the
Xanthocillin biosynthetic pathway in A. fumigatus reveled a multistep process beginning
with the conversion of L-tyrosine to an intermediate by XanB, similar to isocyanide
synthase IsnA/PvcA in bacteria; this intermediate then undergoes an oxidative
dimerization to Xanthocillin catalyzed by a cytochrome P450, XanG; Formyl and methyl
derivatives of Xanthocillin are synthesized by XanA (homologue of InhA from
Pseudomonas sp) and the methyltransferase XanE respectively56 (Fig. 2.B). An
analogous biosynthetic pathway has been observed in yeast Saccharomyces cerevisiae,
involving the sporulation specific genes, Dit1 and Dit2. Dit1, which is homologous to
XanB, converts tyrosine into an isocyanide-functionalized, tyrosine-derived precursor
and ultimately to N-formyl tyrosine; this is then converted to N,N-bisformyl dityrosine
by Dit2 which is a member of the cytochrome P450 family and a XanG homolog56–58
(Fig. 2.B). It is important to note here that the existence of the isocyanide formed in the
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first step of the biosynthetic reaction catalyzed by Dit1 has not been observed in yeast,
although it is entirely possible that the isocyanide group is rapidly hydrated to formyl
group by a hydratase in yeast. This provides mechanistic rationale for the observation that
isocyanide synthases and isocyanide hydratases often exist in pairs and the synthesis of
the latter is often induced by the presence of isocyanide32. A better understanding of
isocyanide biosynthesis and metabolism may elucidate the ways in which soil-dwelling
microbes balance defense and stress response in the soil microbiome.
1.1.1.c Biological targets of terrestrial isocyanides: The pvcA-D gene cluster in
Pseudomonas aeruginosa encodes the isocyanide natural product paerucumarin, as
mentioned previously. Interestingly, mutations in the pvc gene operon in P. aeruginosa
MPAO1 resulted in downregulation of the expression of another gene cluster, the cup
operon (cupB, cupC). Cup proteins are responsible for attachment to abiotic surfaces and
biofilm development in various infection sites. This indicates that the pvc gene cluster
controls biofilm formation in P. aeruginosa by regulating the cup gene operon using
paerucumarin as a signaling molecule59. The transcriptional factor Ptxr upregulates the
pvc gene cluster to synthesize paerucumarin, which in turn activates either the CupB/C
two component regulatory system or the roc system. This occurs with the help of
histidine sensor kinases, RocS1 and RocS2, which either directly activate RocA1 and an
unknown effector “X” or indirectly via, an unknown transcriptional activator “Y”; this in
turn upregulates cupC1-3 and cupB1-6 expressions respectively59,60 (Fig. 3).
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Fig. 4: Isocyanide SF2768 is synthesized by the SfaABCDE operon in S. thioluteus. This isocyanide is
a chalkophore; it is transported outside the cell membrane by Orf12 where in, it chelates copper (I) and
transports it into the cell via ABC transporters (Orf 9-21). Inside the cell, the chalkophore bound
copper is released and SF2768 is regenerated for another cycle of copper chelation.

There is an intriguing possible connection between isocyanide natural products and
biofilm formation mediated by iron availability. Biofilm development in several
pathogenic bacteria, such as L. pneumophila 61, P. aeruginosa 62, S. aureus 63,64, etc, is
induced by low levels of intracellular iron. Under conditions of iron limitation, P.
aeruginosa synthesizes two endogenous siderophores, pyoverdine and pyochelin, which
are responsible for iron acquisition from the host 65 and subsequent biofilm development
around infection sites66–68. As mentioned previously, under conditions of iron limitation
the Pvc gene cluster directs the synthesis of the siderophores pyoverdine and pyochelin as
well as the isocyanide paerucumarin and its formyl form pseudoverdine 45. It would be
interesting to determine if paerucumarin and pseudoverdine can chelate iron, possibly
pointing to an interaction between these isocyanide and isocyanide-derived natural
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products and the expression of genes critical for biofilm development in P.
aeruginosa62,69. If validated, isocyanide-induced biofilm development would be a novel
mechanism for biofilm formation in P. aeruginosa and other pathogenic strains
possessing the pvcA-D operon homologs. Moreover, Ferric uptake regulator (Fur) is an
iron dependent transcription factor that regulates the expression of genes critical for
biofilm development, and the major intracellular iron regulator in P. aeruginosa62,69.As
such, it would be interesting to analyze the interplay between the cup genes (CupB1-6
and CupC1-3) and the fur responsive genes in promoting pathogenesis and biofilm
synthesis.
The notion that isocyanides may act as siderophores is supported by their intrinsic
ability to form complexes with a variety of transition metals70,71, inherent affinity towards
hemoproteins72,73, and also by a large body of correlative experimental evidence
suggesting that pathogenic bacteria synthesize isocyanides to chelate metals and promote
survival in hosts. As mentioned previously, Mycobacterium tuberculosis, the causative
agent for tuberculosis, contains the Rv0096-0101 biosynthetic operon that encodes two
isocyanide-functionalized lipopeptides,INLP1 and 2; these two show structural homology
to isocyanide antibiotics SF2768 and SF2369 from Actinomecetes sp53. This conserved
biosynthetic operon (Rv0096-0101) appears critical for survival and pathogenesis of M.
tuberculosis in macrophages. While the mechanism of this remains undiscovered, there is
the possibility that the Rv0096-0101 encoded genes facilitate metal uptake, transport, and
homeostasis in the pathogenic bacteria.
Additional evidence for an isocyanide-transition metal connection is provided by
CtpA and CtpB: two heavy metal-translocating ATPases located near the isocyanide
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biosynthetic gene cluster in the genome of M. tuberculosis. The expression of CtpB is coupregulated with the isocyanide biosynthetic gene cluster (Rv0096-0101) under
conditions of zinc limitation 53,74,75. Deletion mutations in this conserved isocyanide
biosynthetic gene cluster (mmaA-E) in the pathogenic mycobacterium M. marinum
resulted in a significant drop in intracellular zinc accumulation, consistent with the
observation that this isocyanide biosynthetic gene operon is important for metal uptake
and transport in pathogenic mycobacterium53. However, there is currently no direct
evidence of metal chelation by the encoded isocyanide lipopeptides and a detailed
mechanism of metal uptake and the resulting interactions between the isocyanides and the
components responsible for regulating metal homeostasis in these pathogens is unknown.
There is a more direct connection to metal binding in the isocyanide antibiotic
SF2768 produced by Streptomyces thioluteus. SF2768 is a chalkophore, that is, a
molecule that binds to and facilitates acquisition of extracellular copper. To acquire
extracellular copper, SF2768 (Fig. 5) is transported across the cell membrane by Orf12, a
member of the major facilitator superfamily (MFS) exporters. SF2768 chelates and
converts environmental copper (Cu2+) to Cu+ to form an SF2768-Cu+ complex, which is
then transported inside the cell by an ABC transporter encoded by genes Orf9-21 in the
isocyanide biosynthetic (sfa) gene cluster. Once inside the cell, the chelated Cu+ is
released binds to several Cu-dependent enzymes critical for growth and development as
well as secondary metabolite synthesis (by tyrosinase-like copper containing
monooxygenases) in Streptomyces species 54,76–78.The SF2768 is regenerated and ready
for another cycle of copper acquisition54 (Fig. 5). SF2768 derivatives are also copper
chelators; the isocyanides have the highest copper chelating activities, followed by the
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partially hydrated metabolites. The diformamides have no detectable copper chelating
activity, indicating that the presence of isocyano group(s) is directly responsible for
copper binding and transport 55.
Unsurprisingly, SF2768 and its derivatives are not the only instances of
isocyanides potentially acting as chalkophores. Human pathogen Aspergillus fumigatus
AF293 genome contains four isocyanide synthases (ICs), CrmA, IcsA, IcsB and XanB,
spread across three biosynthetic gene clusters (ICS3G, ICS4G and ICS5G), as mentioned
previously 56. The biosynthetic gene cluster ICS3G, consists of four genes (crmA, B, C
and D), referred to as the crm cluster, which are expressed only in copper limited
conditions and their expression patterns are strikingly similar to that of high affinity
copper transporter ctrC. The expression of crmA-D is not upregulated in iron deplete
conditions, thus indicating their specific transcriptional response to copper. MacA, AceA
and CufA are three copper binding transcription factors present in most pathogenic fungi,
including Aspergillus sp, involved in copper uptake during copper depletion,
detoxification of copper at toxic levels and both, respectively56,79. MacA induces the
expression of the crm cluster under copper depleted and replete conditions56 while AceA
and CufA has no effect. Interestingly, out of the four crm genes, crmC and crmD encode
copper and iron transporters respectively, but the mechanism of copper or iron uptake and
transport by crmD and crmC encoded transporters remain unclear.
Promoting virulence of a pathogen in a host requires survival of the pathogen
inside the host. An important determinant of pathogenicity is to overcome the host’s
natural immune defense. 80 One commonly used mechanism for subverting the host
defense is disruption of host redox homeostasis79,81. Isocyanides have been shown to
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promote pathogenicity by inhibition of copper-containing enzymes. Copper plays an
essential role in the host’s innate immunity, either by serving as cofactor to
physiologically important enzymes, promoting differentiation, maturation and
proliferation of leukocytes, or by ensuring proper neutrophil and macrophage functions
against pathogens82–86. Therefore, isocyanides chalkophores can inactivate the host’s
innate immune defense machinery by disruptive copper sites in these proteins.
An example of an isocyanide that inactivates copper-dependent enzymes involved
in mediating proper host immune functioning is rhabduscin. Rhabduscin is synthesized
by insect pathogens Xenorhabdus nematophila and Photorhabdus luminescens (Fig. 2.B)
and can inhibit the copper-dependent enzymes phenoloxidase and tyrosinase at
nanomolar concentrations 51. These metalloenzymes contribute to the immune defense of
an insect host by synthesizing and depositing melanin, which insects use as protective
layer to seal out pathogens87,88. Therefore, rhabduscin promotes pathogenesis both by
disrupting the host’s ability to synthesize melanin and through its antimicrobial properties
that kill competitors and enhance pathogen survival in host insect cadavers.
Other isocyanides also inhibit tyrosinase. For example, melanocin A (Fig. 6) an
isocyanide antibiotic isolated from Eupenicillium shearii, inhibits mushroom tyrosinase
and subsequently melanin biosynthesis (IC50 of 9nM). Structurally related compounds
lacking the isocyanide functional group, namely, Melanocin B and C, failed to inhibit
tyrosinase, thus indicating that the isocyanide group is essential for inhibition89. Several
cyclopentyl-type isocyanides from Trichoderma harzianum MR304, were all inhibitors of
melanogenesis in Streptomyces bikinienesis and B16 melanoma cells; they inhibited
mushroom tyrosinase, and consequently melanogenesis, with IC50 values of 0.25 µg/ml
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and 0.05µg/ml respectively 90. The precise mechanism by which isocyanides inhibit
tyrosinase is unclear, but competitive binding of the isocyano group of the inhibitor to the
copper in the active site of tyrosinase has been speculatively proposed 91. It is not known
if there are isocyanides that inhibit metalloenzymes involved in the human immune
system or are implicated in protection against other human diseases, which is an avenue
for future research.
1.1.1.d Types of terrestrial isocyanides (Fig. 6):
i. Xanthocillin-class isocyanides: Xanthocillin was isolated from Penicillium notatum
by Rothe, as a complex mixture of xanthocillins X, Y1, Y2 and Z. The members of this
group are all structurally related to xanthocillin (Fig. 6), with variations in the groups on
their aromatic rings 2. Interestingly, studies show that xanthocillin has also been produced
outside the planet Earth, in space; Penicillium expansum 2-7 and Penicillium
chrysogenum, resident strains of the orbital complex, Mir, which became the dominant
strains at the end of a long term space flight, produced secondary metabolites,
xanthocillin X and questiomycin A92,93. Aspergillus is another important source of
xanthocillin and its derivatives 94,95,96 such as xanthocillin X dimethylether (XDE) and
xanthocillin X monomethylether (XME) (Fig.6). XME has also been isolated from
Dichotomomyces cejpii, where it acts as an inhibitor of prostaglandin biosynthesis and
platelet aggregation 94,97. Other important xanthocillin-derived isocyanides include
xanthoascin, isolated from Aspergillus candidus 2,94,98 and emerin, a naturally existing dicyano analogue of xanthocillin2, isolated from the mycelium of Aspergillus nidulans 94,99
(Fig. 6). BU 4704 is another xanthocillin-type isocyanide which was isolated from
Aspergillus sp by Tsunakawa et al 100. Aspergillus fumigatus co cultured with
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Streptomyces peucetius resulted in the synthesis of a formyl xanthocillin analogue,
known as fumiformamide 101.
Biological activity of Xanthocillin class isocyanides:

Fig. 5: TOP: Xanthocillin type isocyanides; BOTTOM: Cyclopentyl type isocyanides. Together,
xanthocillins and cyclopentyls cover the largest percentage of non-marine isocyanide natural
products. Structures constructed using ChemDraw (PerkinElmer).

Xanthocillins as antibacterial and antiviral agents: Isocyanides are natural products
produced by certain microbes in secondary metabolism and almost all of them are potent
antibiotic agents. The Xanthocillin complex (X, Y1, Y2, Z) exhibits a wide range of
activity against both gram positive and negative bacteria as well as fungi and yeasts2.
This broad spectrum antimicrobial property of Xanthocillin may be the reason that the
producer fungal strain, Penicillium, was the dominant surviving fungus on the Mir space
station after long term flight92,93.Three di-hydrogenated forms of Xanthocillin, namely
NK372135 A, B and C, isolated from the fungus Neosartoria fischeri var. glabra
IFO9857, strongly inhibits the growth of Candida albicans in vitro with IC50 values of
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2.12, 0.53 and 0.27 µg/ml respectively 102, thus providing potential therapies against
candidiasis.
The xanthocillin mono methylester (XME), xanthocillin dimethylester (XDE) and
methoxy xanthocillin dimethylether derivated isolated from Apergillus sp. exhibit antiviral activity. These xanthocillin derivatives are active against Newcastle disease virus
(NDV), the causative agent for Newcastle disease, a contagious bird disease that is
easily transmissible to humans. Xanthocillin esters are effective against herpes simplex
virus and Bacillus subtilis 103. They are, however, not effective against the plant
pathogen tobacco mosaic virus (TMV) 104. This suggests that xanthocillin-derived
antibiotics may be generally less effective against plant viruses, potentially owing to
impaired diffusion of these antibiotics across the protective plant leaf cuticle layer104.
More studies are required to confirm this hypothesis.
The mechanism of action of XME against NDV in cultured cells involves the
reversible inhibition of the synthesis of hemagglutinnin in NDV-infected cells 95 at 15
µg/ml concentration. XME is one of the most effective antiviral inhibitors of protein
synthesis, effectual at low concentrations and with low cytotoxicity 95. Identification of
XME’s physiological targets, inhibitory mechanism against hemagglutinin synthesis,
and role in prevention of hemagglutination requires further study.
A new type of xanthocillin-like antibiotic was isolated from Leptosphaeria sp. L179 in 1990 and named MK4588 or Leptocillin. MK4588 shows strong activity against
several infectious bacterial species (Klebsiealla, Proteus mirabilis, Providencia rettgeri,
Morganella morganii kono) at concentrations ranging from 0.78-12.5µg/ml, but no
activity against E. coli at concentrations as high as 100µg/ml 105. Two other xanthocillin-
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derived compounds, darlucins A and B (Fig. 6), were isolated from Darluca filum. They
exhibit antibacterial (MIC: 2.5-20µg/ml), antifungal (MIC: 2.5-50µg/ml), as well as low
cytotoxic effects against various cell lines, and no phytotoxic effects 106.
Xanthocillins inhibit prostaglandin biosynthesis: Prostaglandins are a family of fatty
acid-derived molecules that are powerful vasodilators and are primarily involved with
causing fever, pain, and inflammation. In 1982, Vane 107 won the Nobel prize in medicine
for his discovery of the mechanism of action of non-steroidal anti-inflammatory drugs or
NSAIDs in the inhibition of prostaglandin biosynthesis, The classical NSAID Aspirin
(acetyl salicylic acid) inhibits the enzyme cyclooxygenase (COX), thereby preventing the
conversion of the fatty acid (arachidonic acid) to prostaglandins, thus providing relief
from pain and inflammation108. Around the same time, Kitahara et al 97 observed that
xanthocillin monomethylether (XME), isolated from cultures of Dichotomomyces cejpii,
reduced prostaglandin (specifically prostaglandin H2) biosynthesis from Arachidonic acid
by 50%. The mechanism of inhibition of PGH2 biosynthesis by XME is unknown.
CSBP is a protein kinase, involved in the biosynthesis of inflammatory cytokines
IL-1 and TNF as a response to a large number of inflammatory signals. There are several
classes of imidazole CSBP ligands which are capable of binding to CSBP and inhibiting
LPS stimulated synthesis of inflammatory cytokines. They also show variable extent of
inhibition of arachidonic acid metabolism by inhibiting the enzymes prostaglandin H
synthase 1 (PGH1) or COX1 and Arachidonate 5-lipoxygenase (5-LO) 109. Boehm et al
synthesized a new class of CSBP ligand, 1substituted-4-aryl-5-piridinylimidazoles from
isocyanides (tolyl sulfide isocyanide) utilizing van Leusens’ methodology 110 and
observed that it inhibits 5-LO and Cycloxygenase activity with low potency109.
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Nevertheless, this warrants investigations into the potential inhibitory effect of
isocyanides on cyclooxygenase activity and their possible utility as anti-inflammatory
drugs and analgesics.
Xanthocillins are thrombopoietin receptor agonists: Thrombopoietin (TPO) is a
cytokine that is responsible for the regulation of megakaryocyte and platelet production
via activation of its receptor, MPL or TPO-R 111,112. Recombinant human TPO (rh-TPO)
is currently used for the treatment of chemotherapy-induced thrombocytopenia, a
potentially fatal condition characterized by low platelet count 113,114. However, some
serious limitations with the use of rh-TPO include development of neutralizing antibodies
against TPO and limitation with oral administration (rh-TPO- in unstable in the intestine)
115,116

. Sakai et al, reported that four xanthocillin derivatives, including XDE as the first

natural TPO mimetics, These exhibit TPO receptor agonist activity115,117 and promote the
proliferation of TPO-sensitive human leukemia cell line (UT-7/TPO) in a dose dependent
manner. Yamaguchi et al studied the contribution of the chemical structure of
xanthocillin derivatives towards their TPO-R agonist activity. They observed that TPO-R
agonist activity of these isocyanides are enhanced by alternations in the olefin geometry
and by hydrophobic substitutions on benzene rings 115 but high concentrations of these
compounds inhibit cell proliferation, potentially due to the cytotoxicity of vinyl
isocyanide groups required for their bioactivity. More dose optimization and structureactivity studies of these TPO mimetics are need in order to diminish their toxic effects
and to generate potent replacements of rh-TPO in the treatment of thrombocytopenia.
Complications from the hepato- and cardio-toxicity of Xanthocillins: Townsend et al
classified xanthocillin as “too hepatotoxic for use” 118. Xanthoascin (Fig.5). isolated from
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Aspergillus candidus, has been shown to exhibit hepato- and cardio-toxicity and to
induce teratogeneicity in mice

119,120

. It also causes severe hepatic injury, jaundice, and

focal or confluent necrosis of hepatocytes in mice121,122 , followed by myocardial
degeneration. In addition, xanthoascin generates unique lesions in the liver and the heart,
which are caused by vacuolation of the lung alveolar and myocardial interstitial cell
nuclei 122. Since Aspergillus candidus is an extremely common soil fungus known to
contaminate food, xanthoascin poses a serious risk of food borne liver and heart diseases.
While xanthoascin poses a potentially serious human health risk, there might be other
bioactive isocyanide products, such as the darlucins, which exhibit low cytotoxicity
against various cell lines, and no phytotoxic effects 106; these isocyanides are attractive
targets for therapeutic interventions and drug design. Several isocyanides, such as,
brasilidine A, from Actinomycete Nocardia brasiliensis 123, exhibits significant
cytotoxicity against various tumor and multidrug resistance cell lines124 and can be used
as anti-cancer agents.
Xanthocillins as anti-malarials and inhibitors of melanin biosynthesis: The
xanthocillin-type alkaloid, cordyformamide, was isolated from the fungus Cordyceps
brunnearubra and is toxic to the malarial parasite Plasmodium falciparum but has low
toxicity to human breast cancer cells. It is not cytotoxic towards other cancer cells, such
as small cell lung cancer, epidermoid carcinoma, etc 125. Cordyformamide has a structure
similar to that of melanocin A, a melanin biosynthesis inhibitor (IC50 of 9nM) isolated
from the fungus Eupenicillium shearii 89. Cordyformamide possesses two formamide
groups instead of the isocyanide group found in xanthocillin Y2, while melanocin A
possesses one formamide and one isocyanide group (Fig.5). 125. Interestingly, melanocin
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B and C, which are structurally related to Melanocin A but do not possess isocyanide
groups, failed to inhibit tyrosinase. Because tyrosinase is involed in the biosynthesis of
melanin, the isocyanide moiety in the compounds appears to be critical for their
inhibitory effect on melanin production89.
Xanthocillins as anti-tumor agents: Xanthocillin dimethyl ether (XDE) inhibits the
proliferation of liver HepG2, breast cancer MCF-7, and human oral carcinoma KB cells
with IC50 values of 0.18, 0.38 and 0.44 µg/ml respectively 126. Investigation into the
mechanism of action of XDE against tumor cells revealed activation of pro-apoptotic
pathways and increased levels of reactive oxygen species (ROS) 126. It is possible that
XDE targets ROS-regulated apoptotic pathways in cancer cells. A xanthocillin-derived
compound isolated from the marine organism Penicillium commune, SD118-xanthocillin,
inhibits the growth of a large number of cancer cell lines in a dose dependent manner. Its
mechanism involved inducing autophagy by downregulating the MEK/ERK pathway
along with upregulating PI3K/Beclin 1 signaling 127.
ii Cyclopentyl-type isocyanides: Trichoderma, a common soil fungus, is the primary
source of all cyclopentyl-type isocyanides. The first isocyanide of this type to be reported
was dermadin (previously known as U-21963). It was isolated from Trichoderma viride
in 1966 128,129, almost 10 years after the discovery of Xanthocillin in the fungus
Penicillium notatum. The members of this group of isocyanides vary primarily in their
oxidation levels and degrees of hydration 2 (Fig.5). Dermadin and another related
isocyanide, Trichoviridine, were also isolated from Trichoderma koningii 130 128.
Trichoviridine has also been isolated from various other sources and called different
names, including compound 142B from Tricoderma sp, and isonitrin B from strain
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OMRL 3200 (Trichoderma hamatum) 2,128,131. An isomer of isonitrin B has been isolated
from Trichoderma harzianum l2. Isonitrins A and D were isolated from Trichoderma
harzianum and Trichoderma hamatum respectively 2,132. Two new cyclopentyl-type
isocyanides were isolated from Trichoderma hamatum133 , a spirolactone and a methyl
ester2 (Fig.5). Several volatile isocyanides have been isolated from Trichoderma
koningee, named homothallin 1, homothallin 2, and their related amine and N-formyl
derivatives 134 2,135. Homothallin 2 has also been isolated from a mutant strain of
Trichoderma harzianum (the wildtype strain was not a producer of homothallin 2) 136.
Biological activity of Cyclopentyl-type isocyanides:
Antibacterial and antifungal properties of cyclopentyls: Cyclopentyl-type isocyanides
are antibacterial (effective against both Gram negative and positive) and antifungal
agents, similar to the previously discussed xanthocillins2,132. Trichoderma, the primary
source of these cyclopentyl-type isocyanides, is widely used as a biocontrol agent; it
inhibits the growth of other organisms in its vicinity. It is possible that the biochemical
mechanism of this competitive advantage might include the biosynthesis of toxic
secondary metabolites including isocyanides 135,137.
Cyclopentyl isocyanides contribute to ill thrift disease and alteration of rumen
bacterial metabolism: “Ill thrift” (failure to thrive or FTT) is a common disease in
ruminating animals 138, and is characterized by impaired growth, muscular dystrophy,
anemia, and ketosis of the affected animal. Ovine ill thrift is contracted when sheep feed
on pastures contaminated with Trichoderma. Cyclopentyl-type isocyanides secreted by
Trichoderma sp, such as trichoviridin, dermadin, and 3-(3-isocyanocyclopent-2enylidene)-propionic acid (Fig.5) from Trichoderma hamatum 139,140 cause ill thrift
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disease. The primary target of these Trichoderma metabolites is the bacteria that digest
the cellulose in ruminating animals. The cyclopentyl isocyanides deplete beneficial
rumen bacteria in the affected animal, causing disease 141. The inhibitory mechanism of
these toxic Trichoderma isocyanide metabolites on beneficial rumen bacteria has been
studied extensively. 3-(3 isocyanocyclopent-2-enylidene)-propionic acid induces
carbohydrate fermentation changes in the rumen that are related to ill thrift disease 142,143
by increasing the production of acetate from carbohydrates for most of the 11 tested
strains of rumen bacteria. However, some strains showed a net decrease of acetate
production relative to the synthesis of other acidic fermentation products. 3-(3
isocyanocyclopent-2-enylidene)-propionic acid also causes nutritional deprivation of the
animal 142.
Digestion of the cellulose in timothy hay, a type of grass was inhibited by 2-5
µg/ml of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid in a mixed culture of
rumen bacteria. 12 µg/ml of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid
inhibited the fermentation activity of rumen fluid, measured by its dehydrogenase activity
(DHA); DHA of rumen fluid decreases by 50% upon a 30-minute incubation with this
metabolite, thus indicating that the primary inhibitory step is extremely rapid 144.
Interestingly, this inhibitory effect of the isocyanide on rumen fluid fermentation and
cellulose digestion by rumen bacteria is significantly reduced by the introduction of
equimolar amounts of Nickel (Ni2+) and Cobalt (Co2+) respectively, into the system.
Palladium and chromium ions are also capable of reducing the inhibition. Given the
known affincity of isocyanides for metals, these metal ions may polymerize144 the
isocyanide, thereby reducing its concentration and anti-bacterial effects.
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One of the causes of ill thrift is cobalt deficiency 145. Cobalt is converted to
Vitamin B12 (cobalamin) by the rumen bacterial flora of ruminating animals 146. A
deficiency in the production of vitamin B12 resulting from lack of cobalt causes impaired
propionic acid metabolism in the liver, hepatic dysfunction, suppressed appetite, and
impaired growth, ultimately resulting in ill thrift 147,148. This finding is consistent with
other results that point to transition metal biochemistry as an important axis of isocyanide
natural product activity.
Cyclopentyl isocyanides inhibit pleiotropic resistance (PDR) in bacteria and possibly
multidrug resistance (MDR) in humans: One of the major persistent issues with the
use of anti-cancer drugs is a phenomenon called multidrug resistance (MDR). In MDR,
the ATP binding cassette (ABC) transporter proteins expel a wide variety of anti-cancer
drugs from the cells. Because MDR reduces chemotherapy efficacy, developing
inhibitors of these drug efflux pumps is a high priority 149. Pleotropic drug resistant
protein 5 (Pdr5p) is an ABC transporter that acts as a drug efflux pump and is implicated
in pleiotropic resistance (PDR) in Saccharomyces cerevisiae. This phenomenon is
functionally similar to multidrug resistance (MDR) in mammals caused by the ABC
transporter protein P-glycoprotein 150,151. The cyclopentyl-type isocyanide 3-(3isocyanocyclopent-2-enylidene)-propionic acid was isolated from cultures of
Trichoderma sp. P24-3 while screening for inhibitors of MDR in tumors. In Pdr5p
overexpressing cells, this isocyanide is capable of inhibiting Pdr5p-mediated efflux of
cerulenin , a fatty acid synthase inhibitor 152. 3-(3-isocyanocyclopent-2-enylidene)propionic acid is also capable of inhibiting efflux by the Pdr5p homologs Cdr1p and
Cdr2p in the pathogenic yeast, Candida albicans. 151 The mechanism of inhibition of
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Pdr5p by the isocyanide is unknown, although it does not appear to be due to the
downregulation of PDR5 gene expression or Pdr5p protein levels. Therefore, isocyanide
inhibition must specifically targeting Pdr5p function 151. There is also a need to determine
the effect of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid on mammalian drug
efflux pumps, and to determine the role of this cyclopentyl-type isocyanide in
overcoming multidrug resistance in humans as a viable cancer treatment strategy.
Cyclopentyl isocyanides inhibit tyrosinase and melanin biosynthesis: Tyrosinase is a
copper-dependent enzyme found in both prokaryotes and eukaryotes that is responsible
for the biosynthesis of melanin 91. During the late 1990s and early 2000s, many research
groups focused on screening microbes for the production of secondary metabolites which
inhibit the process of melanin synthesis (melanogenesis) by directly inhibiting tyrosinase
153

. Several tyrosinase inhibitors were isolated 90 from Trichoderma harzianum MR304,

two of which were novel. All of the identified inhibitors were cyclopentyl isocyanide
compounds and inhibited melanogenesis in Streptomyces bikinienesis and B16 melanoma
cells with submicromolar IC50 values. The two newly discovered isocyanides were named
MR566A or 1-(3-chloro-1,2 dihydroxy-4-isocyano-4-cyclopenten-1-yl) ethanol and
MR566B or 1-(1,2,3—tri-hydroxy-3-isocyano—4-cyclopenten-1-yl) ethanol. The other
isolated isocyanides included 1-(1,4,5-trihydroxy-3-isocyanocyclopenten-2enyl)ethanol, 2-hydroxy-4-isocyano-α-methyl-6-oxabiocyclo[3.1.0]hex-3-ene3methanol, 4-hydroxy-8-isocyano-1-oxaspiro[4.4]cyclonon-8-en-2-one, MR304A,
methyl-3-(1,5-dihydroxy-3-isocyanocyclopent-3-enyl)prop-2-enoate90,90,154. The
mechanism of inhibition of tyrosinase by these isocyanides is unknown, although the
copper in the active site of the tyrosinase enzyme is a likely target. The inhibition of
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tyrosinase by several isocyanides, including the homothallin 2 structural analog isolated
from marine Trichoderma viride H1-7 91,155, suggests a shared mechanism.
Possible involvement of cyclopentyl isocyanides in fungal reproduction:
Phytophthora cinnamomi Rands is a soil-borne fungus and a plant pathogen responsible
for the widespread root rot disease in plants. This fungus is heterothallic with compatible
mating strains A1 and A2 156. Brasier 157,158 observed that certain volatile metabolites
from Trichoderma viride were able to stimulate oospore production by the A2 mating
type and not the A1 mating type of Phytophthora cinnamomi Rands following a
homothallic pattern. Pratt et al 134 observed the same oospore induction in the A2 mating
strain of Phytophthora cinnamomi Rands by metabolites from Trichoderma koningii.
These volatile metabolites from Trichoderma koningii were identified as the cyclopentyl
isocyanides homothallins 1 and 2 2. The mechanism of induction of homothallic
oospores in Phytophthora cinnamomic A2 mating type by homothallins remains unclear.
iii Assorted other terrestrial isocyanides: Non-marine natural isocyanides that do not
fall into either the Xanthocillin or Cyclopentyl classes are discussed below.
Mannitol-containing isocyanides, A32390A and brassicicolin A: 1,6-di-O-92isocyano-3-methylcrotonyl-mannitol or A32390A is a novel antibiotic and antifungal
agent isolated from the culture of the fungus Pyrenochaeta sp. A32390A is effective
against the pathogenic yeast Candida albicans, the causative agent of the Candidiadis
infection in humans 159,160. A32390A is also a dopamine beta hydroxylase (DBH)
inhibitor with an IC50 value of 1.7µg/ml 161. Like several other molecular targets of
isocyanide natural products, DBH is a copper-containing oxygenase. DBH catalyzes the
conversion of dopamine and other phenylethylamine derivatives to the neurotransmitter
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norepinephrine using ascorbic acid as a cofactor 162,163. Deficiency of DBH results in
impaired synthesis of catecholamines such as norepinephrine and epinephrine in the
central and peripheral nervous system with a concurrent increase in serum dopamine
levels 164. This condition of increased dopamine/norepinephrine ratio is known as
“norepinephrine deficiency” and it affects the autonomic nervous system. Physiological
effects of norepinephrine deficiency include perturbed blood pressure regulation, elevated
serum dopamine levels, and certain mental disorders 165–168. When injected
intraperitoneally or subcutaneously, A32390A reduces heart and adrenal norepinephrine
levels with a concurrent decline in blood pressure without any hepatotoxicity in DOCA
hypertensive rats. It does not affect brain norepinephrine levels when injected and is
ineffective when administered orally 161,169–171. Oral administration of isocyanides is
likely to be generally problematic, as the isocyanide moiety is acid-labile and unlikely to
survive passage through the stomach. Like most other isocyanides, the mechanism of
A32390A inhibition of DBH is unknown but likely involves interaction of the isocyanide
moiety with the active site copper ion of DBH. Research is also required regarding the
potential effect of A32390A in the induction of the mentioned disorders.
Another structurally similar isocyanide with a d-mannitol core is brassicicolin A,
isolated from the plant necrotrophic fungus Alternaria brassicicola172. It is a potent
antibiotic against Bacillus subtilis and Staphylococcus aureus 173. Interestingly,
brassicicolin A is a phytotoxin (up to a concentration of 5mM) and a phytoalexin, which
is a defensive chemical produced by plants as a defense mechanism against pathogenic
infections, produced by infected Brassica juncea plants, unlike the other isocyanides
discussed so far 174,175.
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Indole-containing isocyanides: B371 is a novel indole containing isocyanide antibiotic
isolated from Pseudomonas sp. 176. A similar isocyano indole metabolite, brasilidine A,
was isolated from Actinomycete Nocardia brasiliensis 123 and possesses significant
cytotoxicity against various tumor and multidrug resistance cell lines124.
Hazimicin factors 5,6: The hazimicins are a novel class of isocyanide antibiotics
(hazimicin factors 5 and 6), isolated from Micromonospora echinospora var challisensis
SCC 1411 177 ; they are isomers that are interconvertible in presence of water 2,21,178.
Aerocyanidine and Aerocavin: Aerocyanidine, an isocyanide antibiotic primarily
effective against gram positive bacteria, was isolated from cultures of Chromobacterium
violaceum ATCC 53434 179. In the same year, another isocyanide anttibiotic called
aerocavin was isolated from the same bacterium and is effective against both gram
positive and negative bacteria180.
1.1.2 Non-terrestrial isocyanides: All isocyanide natural products produced by marine
organisms are terpenoids (isoprenoids), and maybe diterpenoids (4 isoprene units) or
sesquiterpenoids (3 isoprene units). The first marine isocyanide to be discovered was
axisonitrile 1, a sesquiterpenoid, from the sponge Axinella cannabina 20. This portion of
the review will focus primarily on the types of marine isocyanides and their biological
roles, biosynthesis and biochemical targets.
1.1.2.A Types of marine isocyanides: Depending on the number of isoprene units in
their structures, marine based isocyanides can be classified into monoterpenoids,
diterpenoids and sesquiterpenoids. This next section will briefly cover the different types
of marine isocyanides and their biological roles. A more in depth and comprehensive
coverage of this topic is available in previously published reviews 2,19,124,181,182.
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i. Monoterpenoid marine isocyanides: This group mainly consists of monoterpenoid
indole containing isocyanide alkaloids, synthesized primarily by blue green algae of the
stigonemataceae family. Hapalindole A was the first such monoterpenoid indole
isocyanide to be discovered from the cyanophyte Hapalosiphon fontinalis (Ag.) Bornet
192

. This was followed by the discovery of eighteen additional isocyanide functionalized

indole alkaloids from the same cyanophyte, named hapalindoles C-Q and T-V 183. The
monoterpenoid type isocyano alkaloids can be classified into three primary groups124:
(a) the C21 indole alkaloids, which includes the hapalindoles, maybe further classified
into tetracyclic and tricyclic depending on the presence or absence of a C4-C16 bond.
Other C21 type of isocyanides are the fischerindoles, which are basically tetracyclic
hapalindoles modified to possess a C2-C16 bond rather than the C4-C16 bond.
(b) the oxindoles and the oxygenated C21 indoles which include the hapaloxindoles, the
hapalonamides, the hapalindolinones, and the welwitindoles.
(c) the C26 indole alkaloids which include the ambiguines.
A thorough account of these indole isocyano alkaloids can be found in the
reviews published by C.W.J Chang124 and by Bhat et al 185. These monoterpenoid
isocyanide natural products are bioactive agents, primarily exhibiting antimicrobial
properties, just like the terrestrial isocyanides40,185–187. Most of these natural metabolites
are antifungal agents41,188,189; Ambiguines A-F and hapalindoles G and H were isolated
from Fischerella ambigua 190 185; Ambiguines H and I exhibit both antifungal as well as
antibacterial properties with MIC values comparable to streptomycin, puromycin and
amphotericin41. Ambiguine isocyanides A, K and M show potent inhibitory activity
against M. tuberculosis and B. anthracis 40. The terrestrial cyanobacterium Fischerella
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sp is responsible for the synthesis of several isocyanide alkaloids which exhibit potent
antimicrobial activities, such as Hapalindole A and Fischerindole L isolated from the
cyanophyte Ficherella muscicola, shown to inhibit the growth of A. oryzae, P. notatum,
S. cerevisiae etc

191

. Hapalindole T, isolated from the cyanobacterium Fischerella sp that

grows in the bark of the Neem tree, is active against multiple pathogenic bacterial species
such as M. tuberculosis, S. aureus, P aeruginosa, S. typhi, E. aerogens, E. coli, etc 192.
Hapalindoles A-H inhibit the growth primarily of pathogenic gram positive bacteria such
as, Streptococcus sp (S. pneumoniae, S. faecium, S. pyogenes, S. epidermidis etc) 185.
Fischerella ambigua UTEX 1903 synthesizes several hapalindole type isocyanides,
namely fischambiguines A and B, ambiguines P, Q and G, out of which fischambiguine
B shows strong inhibitory activity against M. tuberculosis 40. The welwitindolinone
isocyanide alkaloids, including welwitindolinone A isocyanide, are known for their
antifungal and anti-larval properties and are produced principally by the blue green algae
Hapalosiphon welwitschii 38. The welwitindolinones are not the only isocyanide natural
products with insecticidal activities; Hapalindole L, 12- epi hapalindole C, 12-epi
hapalindole E and 12-epi hapalindole J all kill Chironomus riparius larvae 185,193. A more
detailed account of the antimicrobial activity of this class of isocyanides is discussed by
Bhat et al 185. Surprisingly, some of these alkaloids are also phytotoxic185. Matsumoto et
al isolated ambiguine D from Hapalosiphon sp, which inhibited the growth of plants via
an indirect inhibition of mitosis. This mitotic block was created by the accumulation of
reactive oxygen species (ROS), mainly superoxide anion, generated via ROS-mediated
lipid peroxidation 194–196.
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The fact that most of these isocyanide alkaloids inhibit the growth of pathogenic
microbes is a sharp contrast to some of the previously discussed isocyanides which
potentially help in promoting pathogenicity and survival within the hosts.
Welwitindolinones and ambiguines are isocyanides that are synthesized by two separate
gene operons, well and amb respectively (the well operon encodes well1-3 proteins
which are homologs of the amb products amb1-3, mentioned previously). Both the well
and the amb operon proteins are homologs of the pvcA-D proteins in P. aeruginosa. Most
of the pvcA-D products (including the two siderohphores pyoverdine and pyochelin, the
isocyanide paerucumarin, and exotoxins) have been implicated in the promotion of
pathogenicity and survival within hosts, whereas the homologous welwitindolinones and
the ambiguines products kill pathogenic bacteria and fungi rather than promote their
survival.
Interestingly, welwitindolinones and their analogues have been shown to reverse
P glycoprotein-mediated multiple drug resistance (MDR)124,197–199 in human ovarian
adenocarcinoma cell line (SK-OV 3), thereby preventing the expulsion of anti-cancer
drugs. More details about the ability of welwitindolinones and their derivatives to reverse
MDR can be found in the comprehensive review by Bhat et al 185. Most of the
hapalindole-type antibiotics possess anti-cancer properties as well. Kim et al 187 reported
the cytotoxicity of several hapalindoles against different human cancer cell lines,
including HT 29 (colon adenocarcinoma), MCF 7(breast carcinoma), NCI-H460 (large
cell lung carcinoma), SF268 (glioblastoma) and IMR90 (lung fibroblast normal cell) cell
lines. The mechanism of inhibition of cancer cell proliferation by hapalindoles remains
unclear, although it might be a combination of different mechanisms including reversal of
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MDR in drug-sensitive cancers. Another potential mechanism might be via inhibition of
RNA polymerase. Evidence to support this conjecture is provided 12 epi hapalindole E
from Fischerella sp, which acts as an inhibitor of mRNA biosynthesis 200 by targeting
RNA polymerase. The consequences of inhibition of RNA polymerase are manifold,
including the treatment of African trypanosomiasis 201 and the activation of p53mediated apoptosis of cancer cells 202–205. Hapalindoles are also antagonists of the
antidiuretic hormone arginine vasopressin; hapalindole A inhibits vassopressin binding to
the kidney as well as inhibiting kidney vasopressin-stimulated adenylate cyclase185,206,207.
12 epi hapalindoles can be biosynthesized via two pathways185 : L-tryptophan
reacts with geranyl pyrophosphate to form a terpene ((3-Z-20-isocyanoethyl indole)
which can either undergo cyclization with geranyl pyrophosphate or undergo a
chloronium ion mediated reaction with Z-3,7-dimethyl-1,3,6 octatriene to synthesize the
chlorinated hapalindoles (such as 12-epi hapalindole E isocyanide). 12 epi hapalindole E
is the precursor for all chlorinated isocyanide metabolites from H. welwitschii; details of
biogenesis of these indole alkaloids can be found in Moore and Stratmann et al’s study 38
as well as in the review by Richter et al 208. The indole groups of hapalindole alkaloids
are installed by the indolyl vinyl isocyanide synthases (Ambl1-3 and WelI1-3) using the
substrates L- tryptophan and ribulose-5-phosphate 209. Welwitindolinones and
ambiguines have operons (well and amb respectively) which encode isocyanide synthase
(isnA) and oxygenase (isnB) homologs (this has been covered in detail previously). A
thorough description of the biological and chemical synthesis of these monoterpenoid
alkaloids can be found in published reviews 185 124.
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ii. Diterpenoid marine isocyanides: The first reported diterpenoid type isocyanide was
3- isocyano-3,7,11,15-tetramethylhexadeca-1,6,10,14-tertaene 210 from the marine sponge
Halichondria sp, almost a decade before the discovery of the previously described
monoterpenoids. There are three classes of isocyanide diterpenoids:
(a) The acyclic diterpenoids: The first and the only observed acyclic isocyanide
diterpenoid is 3- isocyano-3,7,11,15-tetramethylhexadeca-1,6,10,14-tertaene, isolated
from a mixture of its corresponding isothiocyanate and formamide in Halichondria sp.
Out of all of these compounds which possess antimicrobial properties, this is the only
isocyanide diterpenoid that is acyclic; all other diterpenoid iscocyanides are cyclic124,210.
(b) The kalihinanes: The second class of diterpenoid isocyanide natural products are the
kalihinanes. These are bicyclic organic compounds which possess different types of
tetrahydropyran (THP), tetrahydrofuran (THF) and dihydropyran (DHP) appendages
attached to the carbon 7 position 124. Eleven different types of kalihinanes alcohols
(kalihinols) 124 were isolated from the sponge Acanthella sp by Patra and Chang et al
211,212

. Kanihinols can also possess chloro, or alkene functional groups, and they

constitute about 50% of all diterpenes isocyanides212. A thorough description of
kalihinanes can be found in reviews published by Chang 124 and Garson and Simpson et
al 181. All of the kalihinane isocyanides possess antimicrobial properties 213. Kalihinol A
and F inhibit the growth of bacteria and fungi, such as, S. aureus, C. albicans, B. subtilis
2

. Kalihinol A and two new isocyanide-containing diterpenoids, isokalihinol B and

kalihinene, were isolated from the marine sponge Acanthella klethra. All three
compounds are toxic to fungi such as Mortierella ramannianus and Penicillium
chrysogenum. They are also cytotoxic to P388 murine leukemia cells 214. In addition,
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some of these diterpenoids possess the ability to kill parasitic worms 215,216 and malarial
parasites 217,218. Kalihinenes X,Y,Z, Kalihinol A and 10- formamidokalihinene from
Acanthella cavernosa exhibit antifouling activity against the larval settlement and
metamorphosis of Balanud amphitrite 181,219,220.
(c) The amphilectanes: These are isocyanide-containing alcohols isolated from the
marine sponge, Hymeniacidon amphilecta 221. All of the these diterpenoids are potent
antimicrobial agents and may be further classified into the following types124:
isocycloamphilectanes (primarily isolated from the marine sponge Cymbastela hooperi
222

), cycloamphilectanes (primarily isolated from the sponges Amphimedon sp223,

Halichondria sp 224 , Adocidae sp 225 and Cymbastela hooperi 222) and neo- and preamphilectanes124. The last type of amphilectanes includes only two compounds, 7isocyano isocycloamphilecta-11,15-diene from the sponge Adocidae sp 225 and 7isocyano neoamphilecta-1,15-diene from Cymbastela hooperi 222. The
isocycloamphilectane isocyanide, isocycloamphilectane-7,20-diisocyanoadociane from
the sponge Amphimedon sp, 226 shows antimalarial activity181,222, along with several other
marine isocyanide secondary metabolites 227,228. Although the mechanism of malaria
prevention by these isocyanides is unclear, it may include the ability of isocyanides to
bind iron porphyrins. This is consistent with the aforementioned ability of isocyanide
natural products to act as siderophores. Additionally, isocycloamphilectane isocyanides
may prevent conversion of hemozoin to beta hematin229,230; accumulation of the toxic
heme then leads to disruption of the membranes of the malarial parasite181,231.
iii. Sesquiterpenoid marine isocyanides: Sesquiterpenoids are principally isolated from
marine sponges and molluscs, like the diterpenoids covered in the previous section.
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Unlike the diterpenoids, sesquiterpenoids have only one nitrogenous moeity (-NC, -NCS,
-NHCHO, -SCN or -NCO). There are 105 of these sesquiterpenoids, of which only 35 are
isocyanides while 35 others are isothiocyanates124. Sesquiterpenoids often are present
with diterpenoids in the same organisms and have eight different skeleton types,
discussed below124. One of the most prolific producers of sesquiterpenoids is the sponge
Axinella cannabina, which synthesizes about 33 different sesquiterpenoids, all of which
belong to the P-U skeleton types. The different skeletal types are mentioned below:
(a) Axanes: These were the first marine isocyanide isoprenoid natural products
discovered. The first two sesquiterpenoids bearing the axane skeleton to be isolated were
axionitrile 1 and axisothiocyanate-1 from the sponge Axinella cannabina 20. Since then,
several other axane natural products have been isolated from Axinella cannabina as well
as from a different sponge, Acenthella cavernosa.
(b) Aromadendranes: The first aromadendrane type (Q type) sesquiterpenoids to be
reported were axisonitrile 2 along with its isothiocyanate and amide derivatives,
axisothiocyanate 2 and axamide 2 respectively from the sponge Axinella cannabina 232.
(c) Eudesmane: Acanthellin 1 was the first isocyanide sesquiterpenoid of the eudesmane
type to be isolated from the sponge Acanthella acuta 233. Its corresponding isothiocyanate
and formamides were isolated from a different sponge, A. cannabina 234.
(d) Epimaaliane: First isolated from the nudibranch Cadlina luteomarginata feeding on
the sponge Axinella sp 235, these sesquiterpenoids are also found in the sponge A.
cannabin.A detailed account of these compounds can be found in Chang’s review 124.
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(e) Cadinane: Candinanes are synthesized from amorphene, (-) -10 isocyani-4amorphene, and have been isolated from nudibranches (Phyllidia sp) as well as sponges
(Axinyssa sp, A. cannabina, A. pulcherrima)124.
(f) Spiroaxanes: These types of sesquiterpenoids were first isolated from the sponge
Axinella cannabina, the same sponge that synthesizes the axanes axionitrile 1 and
axisothiocyanate-1. These three novel sesquiterpenoids possess an isocyano,
insothiocyano, or amide groups and were named axisonitrile 3, axisothiocyanate 3 and
axamide 3 respectively 236. Spiroaxane sesquiterpenoids have subsequently been isolated
from several marine sponges, including Acanthella acuta237, A. klethra238, Axinyssa
aplysinoides239, A. cavernosa 240,241, and somes nudibranches, such as Phyllidiia
pustulosa and P. ocellate 240,242.
(g) Bisbolanes: The first sesquiterpenoid of this skeleton type was isolated from the
sponge Theonella swinhoei 243. Of all known bisbolanes, only two have been identified to
possess an isocyanide group 124, although isocyanates and formamides of this type are
frequently found in nature.
(h) Pupukeananes: The first pupukeanane isocyanides were discovered from the
nudibranch P. viscosa feeding on the sponge Hymeniacidon sp. The isolated isocyanides
were 9-isocyanopupukeanane and its isomer 2-isocyanopupukeanane, both toxic to fishes
244,245

.

Like most other isocyanide natural products, almost all sesquiterpenoid isocyanides are
antimicrobial agents221,233,246–248. Metabolites of the marine sponge, Acanthella
pulcherrima, including the isocyanide (-)-8 isocyano-7-aromadendrane, inhibit the
growth of Bacillus subtilis 249. The sponge Axinella sp produces several isocyanide
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sesquiterpenoids, including axisonitrile 2, which exhibit antimicrobial properties and
protect the sponge from being eaten or overgrown248,250. Some of the sesquiterpenoids
also exhibit antimalarial activities similar to the diterpenoids discussed previously.
Axisonitrile 3, its corresponding isothiocyanate, and three other eudesmane
sesquiterpenoids show promise against Plasmodium falciparum, the causative agent of
malaria 238.
Axisonitrile 2 and other sesquiterpenoid metabolites of the sponge Axinella spare
antifouling agents; they prevent the settling and metamorphosis of the larvae of P.
pacifica, S. tribranchiata, H. refescens in marine environments 248,250. Terpenoids from
the sponge Acanthella cavernosa also show antifouling activity against the larvae of the
barnacle Balanus amphitrite, as covered in the section detailing the kalihinanes241.
Nudibranches of the family Phyllidiidae synthesize isocyanide sesquiterpenoids, which
also exhibit antifouling properties against larval attachment and metamorphosis of
Balanus Amphitrite242. Sesquiterpenoids are toxic to fishes as well; for example,
axisonitrile 2 and other metabolites of Axinella sp are poisonous to goldfishes250, (-) 8isocyano-7 aromadendrane and other metabolites from Acanthella sp are toxic to guppies
251,252

. This toxicity may result from isocyanide-induced suppression of feeding in

fishes250 by a mechanism that remains unclear. This isocyanide-induced toxicity of fishes
may bolster the survival of marine sponges by killing off competition, as we have seen in
the case of terrestrial isocyanides conferring survival advantage to isocyanide-producing
microorganisms in the soil microbiome. Nudibranches typically feed on sponges that
synthesize these piscicidal agents, allowing them to use these toxins as defense
mechanisms235,245. Accounts detailing the chemical and biological synthesis of
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isocyanide functionalized di- and sesqui- terpenoids already exist 151 2,124,181,182 and
therefore won’t be covered in details in this review.
1.1.3 Degradation of isocyanides by Isocyanide hydratase (ICH)
Isocyanide hydratase (ICH) (EC 4.2.1.103) was isolated by the Kobayashi group
from Pseudomonas putida N19-2 32. This was the first enzyme discovered that could
convert a wide range of isocyanides into their corresponding formamides via addition of
water to the isocyanide moiety. ICH is induced by the presence of isocyanides in the
growth medium, confirming that isocyanide detoxification activity is not adventitious but
is a specific response to isocyanides. Therefore, ICH plays a key role in the microbial
defense against isocyanide natural products.
Further investigations into this enzyme revealed that it is a ~60 kDa homodimeric
protein encoded by the 684-nucleotide long inhA gene. ICH is a cysteine-dependent
enzyme whose active site Cys101 residue is essential for catalysis. Cys101 initiates
nucleophilic attack at the isocyanide carbon resulting in the formation of a proposed
thioimidate intermediate which is ultimately hydrolyzed to the corresponding
formamide31,253. The thioimidate intermediate in ICH has not been previously observed
using any technique, but it was assumed to be a mandatory intermediate formed by the
nucleophilic attack of Cys 101 on the isocyanide carbon. The work described in this thesis
will describe the first successful visualization of the thioimidate reaction intermediate
during enzyme catalysis in microcrystals using serial femtosecond mix and inject
crystallography.
Kobayashi et al isolated another protein with isocyanide hydratase activity from
Arthrobacter pascens F164. This second ICH enzyme is accompanied by a deformylase
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that acts on isocyanide-derived formamides to give formate and amines 33. Therefore,
this two-enzyme system suggests that Arthrobacter pascens F164 does not simply detoxif
isocyanide natural products but can convert them to common metabolites with welldefined catabolic pathways. A comparison between the Pseudomonas putida N 19-2 ICH
and the Arthrobacter pascens F164 ICH revealed no significant sequence similarity
between the two as well as different structural, biochemical and immunological
properties254.
Previously the Wilson group determined the crystal structure of the 48 kDa
wildtype ICH isolated from Pseudomonas fluorescens at resolution 1.0 Å (PDB:
3NON)31. Site-directed mutagenesis in that study confirmed that Cys101 is catalytically
essential, as mutations at Cys101 (C101S, C101A) resulted in inactive ICH. The active
site Cys101 interacts with Asp17 and Thr102 in the ICH active site. The T102V mutation
results in substrate inhibition, whereas the D17V, D17E and D17E mutations severely
reduce the catalytic ability of ICH. Based on analysis of COOH bond lengths in these
atomic resolution structures, Asp17 was shown to be protonated (neutral) and was
proposed to activate an ordered water that hydrates the thioimidate intermediate. Another
catalytically important residue is Arg214, which was reported to be important for anion
binding near the active site by interacting with anions via its cationic side chain;
suggesting that substrates for ICH may possess an anionic moiety. Interestingly, the ICH
structure is similar to that of human DJ-1, however differences in the to the active sites of
ICH of DJ-1 render DJ-1 incapable of degrading isocyanides. Moreover, these variations
in the ICH active site also disfavor oxidation of Cys101, whereas the active site of DJ-1
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strongly favors oxidation of Cys106 to Cys106 -sulfinic acid, enabling DJ-1 to sense ROS
levels cells.
The work described in this thesis clarified several outstanding mechanistic
questions regarding ICH catalysis by directly observing catalytic turnover using serial
mix-and-inject serial crystallography. In addition, this technique observed nonequilibrium motions in ICH that were activated by covalent modification of Cys101 that
are functionally important for turnover.
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Chapter 2: Introduction
The relationship between internal enzyme conformational dynamics and catalysis.
The role of protein conformational dynamics in enzyme catalysis has been a topic
of much heated debate for several decades 255–258. The central question of this debate is:
do enzyme dynamics contribute directly to transition state barrier crossing (the chemical
event) or are they involved only in substrate binding and product release? Because the
physiochemical basis of enzyme catalysis is still incompletely understood, internal
protein motions and their contributions to effective substrate turnover has garnered much
attention in the past two decades. Motions of amino acid residues, in or around the active
sites, can have significant impact on substrate turnover. As such, the identification and
characterization of such motions and their overall catalytic consequences has become of
paramount significance259,260. This section of the thesis will describe some examples
where internal dynamics in enzymes effect their overall catalysis258,261,262 and delineate
mechanistically how such events affect passage along the reaction coordinate263.This
topic is important for this thesis, which addresses how covalent modifications of the
active site reactive cysteine 101 in Isocyanide Hydratase (ICH) enzyme triggers a chargegated conformational switching of a nearby helix H. This catalysis-activated motion of
helix H is important for efficient ICH catalysis. We propose that several enzymes may
rely on internal active site dynamics for catalysis, particularly when triggered by active
site modification. ICH is the first system, to our knowledge, where cysteine nondisulfide covalent modification directly gates conformational dynamics essential for its
function.
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2.1. How internal protein motions effect enzyme catalysis.
During a catalytic cycle, enzymes can undergo conformational changes during
any of the key catalytic steps, including substrate binding, intermediate
formation/resolution, product formation/release, etc. These motions, which occur on
timescales ranging from milliseconds to seconds264, often define the rate limiting steps
and thus the overall rates of the reactions258,265–269. A common way to estimate the degree
of transition state stabilization by an enzyme is to compare the overall rates of the
enzyme-catalyzed vs uncatalyzed reactions261. However, a limitation of this approach is
that it provides a lower limit for transition state stabilization, as the rate-limiting step may
not be the chemical step. One example of the interplay of enzyme conformational
changes and catalytic rate is the enzyme Ribonuclease A (RNase A)270–272, which
catalyzes cleavage of P–O5′ bonds in RNA272. The enzyme contains two mobile loops,
Loop1 and Loop4. These loops undergo a 2-3 Å conformational change upon
substrate/ligand binding, resulting in switching from the “open” form (optimal for
substrate / ligand binding) to the “closed” form to facilitate catalysis. This conformational
switching, coupled to product release, is the rate limiting step of the reaction273–275,275–284.
However, whether this intrinsic conformational flexibility in RNase A aids catalysis by
stabilizing the transition state remains unclear.
Transition state stabilization could potentially be affected by protein motions,
providing a direct connection between enzyme dynamics and the mechanism(s) by which
enzymes achieve their catalytic effects263,285–287. Transitions states are “balance points of
catalysis” 288, when chemical bonds are being made/broken and the reaction has an equal
probability of going in either direction; it is that fleeting unstable state where a molecule
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is no longer a substrate but is not yet a product 289. All enzymes must stabilize the
transition state for efficient catalysis16–23,23–27, or in other words, minimize the activation
energy of the reaction (energy of the highly unstable transition state) to begin substrate
turnover. Linus Pauling proposed that this likely occurs via selective, tight binding of the
enzyme to the transition state species285. Specific mechanisms that enzymes use to
stabilize the transition state include pre-organizing active site electrostatic
environments302,303, and specific arrays of active site hydrogen bonds that favor binding
to the transition state over the substrate 261,304. As an example that combines these
strategies, Schowen et al’s minireview 305 describes transition state stabilization by
proton bridging in enzymes involved in general acid-base catalysis306. Therefore, enzyme
dynamics may be able to impart dynamic electronic microenvironments to active sites
that are conducive to the formation/stabilization of the transition state species.307
The enzyme Dihydrofolate reductase (DHFR) has been proposed as an example
of enzyme dynamics directly assisting transition barrier passage. E. coli DHFR enzyme
possesses a highly conserved mobile loop308,309310, called the Met20 loop, whose
mobility regulates access of substrate, solvent, and co-factor accessibility to active site
pocket. The open conformation of the Met20 loop facilitates the binding of both NADP+
and folate. Upon binding, the disordered portion of the Met20 loop (residues 16- 20)
undergoes a conformational change to form a hairpin turn that ensures proper alignment
of the nicotinamide and pteridine rings in the active site310. This conformation also
positions residues Ile14 and Met 20 near the active site they exclude water and stabilize
the Michaelis complex via a network of hydrogen bonds and hydrophobic interactions.
To test the influence of Met20 loop mobility on E. coli DHFR catalysis, a mutant that
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deleted four critical hairpin forming residues (16-19) from the Met20 loop (called DL1)
was made. In wild type DHFR, product release is the rate limiting step311. In the DL1 E.
coli DHFR mutant, hydride transfer becomes rate limiting (rate decreases from 950 sec-1
in wildtype to 1.7 sec-1 in DL1 mutant DHFR), arguing that the Met20loop is important
for rate acceleration261,310.
It is possible that the mobile Met20 loop residues in E. coli DHFR play an
important role in “compacting” the active site to correctly position the substrate and the
co-factor and to reduce the total distance between donor and acceptor atoms to promote
hydride transfer 312. Internal active site dynamics in DHFR supports a model of catalysis
where the “open” active site can easily access and bind the substrate and co-factor,
following which the disordered central portion of the Met20 loop adopts a hairpin turn
which stabilizes the transition state310; inability to switch between open and hairpin
conformations in mutant DL1 has a detrimental effect on catalysis310. As such, E. coli
DHFR has been subject to a number of combined experimental and computational studies
to investigate the controversial role of enzyme dynamics in catalysis185,264,278,312–315.
Several of these studies by the Benkovic, Hammes-Schiffer, and Wright groups have
proposed that collective motions in E. coli DHFR can serve as “promoting motions” that
directly facilitate transition state barrier passage, although this is currently debated
288,316,317

.

Other researchers have argued that, although such conformational dynamics can
affect the overall rate of reaction or the rate limiting step of the reaction, they cannot
contribute to catalysis via transition state stabilization or enhancing rates of barrier
passage beyond what is permitted by equilibrium and the Eyring rate theory258,307,318–323.
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One of the primary opponents of dynamical contributions to enzyme catalysis is Arieh
Warshel, who argues that in DHFR and other enzymes, catalysis is achieved by adoption
of a specific electrostatic microenvironment in the enzyme’s active site, not by internal
millisecond conformational dynamics317,324,325. Since most enzymatic reactions involve
polar transition states, enzymes can decrease the activation energy barrier of the reaction
by fashioning active site electrostatics to stabilize these transition states291,299,324,326,327.
Investigations into the connection between protein dynamics and the probability of
reaching the transition state reveal a dominant role for the electrostatic fluctuations of the
protein; if these electrostatic fluctuations differ in enzyme and in solution, they can
contribute to catalysis321,328, otherwise not.
Reconciling the computational finding that dynamical events likely cannot
contribute to catalysis with the results of studies on DHFR (and other enzymes)
indicating that dynamics are important for catalysis is challenging. A plausible model is
that dynamics are important for progress along the reaction coordinate, although they do
not aid barrier crossing per se. In this thesis, we find that the enzyme Isocyanide
Hydratase (ICH) facilitates catalysis via changes in conformational ensembles that are
gated by the formation of a catalytic intermediate. In ICH, the formation of a thioimidate
catalytic intermediate eliminates negative charge on the active site cysteine thiolate that
alters the dynamics of ICH, facilitating subsequent steps of catalysis.
A central concern when considering the connection between conformational
dynamics and catalysis is correlating the timescales of these conformational dynamic
events to key steps in catalysis. If such correlations exist, then the internal protein
motions whose timescales correspond to key steps in catalysis are candidates for
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functionally important motions. Generally, there are three types of protein motions. The
first type is the local motion(s) (10−15 to 10−1sec) which include atomic fluctuations and
side chain mobility. The second type of motions are rigid body motions (10−9 to 1 sec)
which involve the movement of small parts of the protein; they include helix mobility,
domain and subunit motions etc. The third and final type of motion is the large-scale slow
motions (10−7 to 10 sec), which involve helix coil transformations, folding/unfolding etc.
Since the overall enzyme catalyzed reaction rate is related to the activation free energy
barrier height, hypothetically one of the ways in which internal motions could potentially
affect the catalytic rate is by decreasing the height of the activation energy barrier with
the previously mentioned local (10−15 to 10−1sec) or rigid body motions (10−9 to 1 sec). In
most cases, however, the enzyme transition state formation/existence is a femtosecond
(fs) timescale event. Therefore, these rigid body motions (conformational dynamics) are
too slow to stabilize the transition state. In several enzymes, such as DHFR, Triose
phosphate isomerase (TIM), Lactate dehydrogenase (LDH) and beta lactamase, the
internal motions implicated in contributing to catalysis are of the rigid body type and
therefore are too “slow” and cannot stabilize the transition state, but can potentially
facilitate the later steps of catalysis.
Motions that involve substrate/ligand binding and organization of the active site
electrostatic microenvironment to make it conducive for transition state binding, as well
as internal dynamics that enhance populations of transition state accessible
conformations, are slow, often in the scale of microseconds to milliseconds307,329. Faster
fs motions occur after these slower protein motions and can stabilize the transition state
to facilitate product release and to regenerate the native enzyme. However, there is no
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evidence currently available to indicate that these fast motions are actually “directly
linked to the bond breaking and forming process of the transition state”262.
Transition states have lifetimes on the timescale of single bond vibrational
frequencies and as such, coupling of femtosecond (fs) bond vibrations to conformational
motions of the millisecond (ms) scale is highly unlikely329. Warshel et al 330 have
demonstrated that the kinetic energy of the conformational motion associated with
substrate binding is entirely dissipated before the chemical step begins and therefore
cannot affect it. Combined with computer simulations, they establish that in case of
enzyme catalyzed reactions where the chemical barrier is greater than a few Kcal/mol,
there exists no coupling between the chemical step(s) of catalysis and internal protein
conformational dynamics.
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Chapter 3: Introduction
Biochemistry of reactive cysteine residues in enzymes
3.1: The relationship between cysteine covalent modification gated enzyme
dynamics and catalysis.
Although protein dynamics are not likely to contribute to barrier crossing directly,
they can facilitate catalysis by promoting progress along the reaction coordinate. In this
thesis, we explore how conformational dynamics can aid enzyme turnover using
Isocyanide Hydratase (ICH) as a model system. The present study involves reactive
cysteine covalent modification(s) which alter the active site electrostatic
microenvironment, resulting in helical dynamics important for efficient catalysis by ICH.
Having discussed the relationship between internal dynamics and enzyme catalysis in
Chapter 2, we will make an in-depth investigation into how protein dynamics can be
coupled to cysteine covalent modification(s) in cysteine dependent enzymes in this
section.
A multitude of post-translational protein modifications exist and are essential in
mediating proper function for many proteins 331–334. Out of the 20 frequently occurring
amino acid residues in human proteins, cysteine (Cys) is the most reactive due to its
strongly nucleophilic thiolate side chain when ionized332. Cys residues are usually
reactive, redox sensitive, polarizable and extremely sensitive to local microenvironment
electrostatics335. Although cysteine makes up only about 2% 336 of protein amino acids in
mammals, covalent modifications of cysteines have important consequences for protein
function that affect essential processes such as cell growth, repair and death. As a result,
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reactive cysteine residues are frequently located at functionally important sites in proteins
and act as regulatory switches that can controls multiple downstream processes335,337.
Cysteines can be classified into several functional categories, such as catalytic, redox
active, regulatory, structural, metal-coordinating, and some without any known role; a
mini review detailing the description of these classes of cysteine residues is available by
Fomenko et al 337.
Cysteines that control downstream metabolic signaling processes in response to
covalent modifications are widely studied337,338. These modifications arise naturally, as a
consequence of reaction of cysteines with pools of reactive electrophilic metabolites in
the cell 331,339,340. Some common cysteine covalent modifications include alkylation,
oxidation, formation of metal (electrostatic) complexes, etc. Below I delineate the most
common cysteine modifications and review examples of such modification(s) and their
functional effects in cysteine dependent enzyme catalysis.
3.2.a) Unmodified cysteine (neutral thiol/negative thiolate).
An important regulator of the activity of cysteine-dependent enzymes is the redox
state of their immediate microenvironment, which can be altered by the generation of
reactive oxygen species (ROS)341. The d-orbitals of the sulfur atom of the thiol group
allows for numerous oxidation states, permitting a multitude of possible oxidative
posttranslational modifications. Reactive oxygen and nitrogen species can participate in
signal transduction pathways via the reversible or irreversible oxidation of cysteine thiol
groups in redox sensitive proteins, including several cysteine-dependent enzymes
342,343,92–94

. The anionic sulfur atom in cysteine thiolates (R-S-) is the reactive form and is

susceptible to oxidation by a large variety of ROS. Cys can be oxidized to various
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species, discussed in detail later. Therefore, cysteines impart oxidant sensitivity to a
multitude of proteins, with diverse regulatory and signaling consequences 347,348. There
are several examples of cysteine-dependent enzymes of biomedical relevance that have
redox sensing as a primary and secondary activity347. Reversible modifications are often
held to be the most valuable for signaling, and both cysteine sulfenic acid and disulfides
are reversible oxidative modifications that cause active site structural and functional
changes in proteins 349, allowing thiols to act as redox regulatory switches350.

Figure 1: Major oxidation states
of cysteines

The reactive form of thiols (R-SH) is the deprotonated form; the negatively charged
thiolate ion (R-S-) 346. Therefore, thiol pKa value is commonly used to determine if a
particular cysteine residue is likely to be reactive. Because the pKa of an unperturbed
cysteine residue is ~8.5, the electrostatic microenvironment of the active site can easily
promote ionization of a cysteine to the thiolate in the physiological pH range. For
cysteine-dependent enzymes, this pKa depression is important for nucleophilic
catalysis.351. In the work described in this thesis, ICH undergoes active site
conformational switching in response to catalytic cysteine modification, which changes
the active site electrostatic microenvironment. As noted above, the ability to manipulate
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the reaction buffer pH to control the extent of reactive cysteine protonation state provided
us with a useful tool to fine tune the internal CH motions. This portion of the work is
explained in more detail in Chapter 4 of this thesis.
3.2.b) Oxidative cysteine modifications.
As discussed in the previous section, cysteines can act as redox sensing switches via their
ionizable thiol groups. As such, cysteine-dependent enzymes can play important roles in
redox regulation and diseases with a redox component.
Oxidative phosphorylation is the process by which ATP is synthesized in the
mitochondria by the reduction of molecular oxygen to water through a series of electron
transfer events. However, during this process, a small portion of the oxygen does not
convert to water, but is incompletely reduced to generate reactive oxygen and nitrogen
species (ROS/RNS) such as peroxides, superoxides, hydroxyl radicals, peroxynitrite etc.
352, 353, 354

. This induces oxidative stress by perturbing the normal redox state of the cells

and can damage DNA, proteins and lipids, impair cell signaling, energy metabolism, and
cause overall dysfunction of biological activity 355. During oxidative stress, increased
levels of ROS/RNS target cysteine thiols for reversible or irreversible oxidation or
glutathionylation338,356–359 and affect redox sensing and signaling. Fig. 1 summarizes the
major oxidation forms of cysteines. As mentioned above, reversible oxidized species of
thiols with known redox signaling roles are Cys-sulfenic acid and intra/intermolecular
disulfide bonds, including glutathionylation349,360–362.
A) Disulfide formation: Disulfide bonds, or disulfide bridges or S-S bonds (R-S-S-R)
are reversible covalent bonds that form between two proximal cysteine thiols within or
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between individual polypeptide chains, by the oxidation of sulfhydryl groups under
mildly oxidizing conditions359,363–365 (Reaction I).
2 R-SH→ R-S-S-R +2 H+ +2 e-

…………………………. (I)

Disulfide bonds can also form from pre-existing disulfide bonds by the exchange of a
thiol group (R-SH) with the disulfide (R’-S-S-R’) in a reaction called “thiol-disulfide
exchange” or “disulfide scrambling”, catalyzed by various oxidoreductase enzymes 366–
368

. This results in the generation of a new thiol group (R’-SH) containing cysteine and a

new disulfide (R-S-S-R’)369–371 (Reaction II). This is often the rate determining step in the
folding process of certain proteins344 and can occur in several cellular compartments
incluing the ER, the mitochondrial inner membrane space (IMS) in eukaryotes, and the
periplasm in prokaryotes344,372–374.
R′-S-S-R′ + R-SH → R-S-S-R′ + R′-SH …………………. (II)
The comprehensive review by Ziegler depicts a complete list of enzymes whose
functions rely upon disulfide-thiol exchanges375. Elevated H2O2 levels in E. coli cause the
cysteine-dependent OxyR transcription factor to upregulate the expression of antioxidant
genes such as oxyS, katG and gorA to combat the effects of hydrogen peroxide.376. OxyR
is activated by a conformational change resulting from the formation of an intramolecular
disulfide bond between the cysteines Cys199 and Cys208376. OxyR is one of the beststudied examples of disulfide bond-mediated regulation of the cellular antioxidant
response during oxidative stress. Disulfide bond formation can also promote bacterial
pathogenicity and virulence377. While formation of S-S bonds confers structural stability
to the enzyme, it can also act as a redox sensitive regulatory switch (breaking and
remaking of disulfide bonds can regulate enzyme function)364,368,378–381. Moreover, the
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ratio of cysteine to the disulfide (RS-SR)/cystine (CysSSCys) form has been shown to be
dysregulated in several diseases in humans, including atherosclerosis379,382,383 and
cancer384–387. Some examples of established disulfide bond regulation349 include
activation of tissue factor (TF)388, redox sensing and allosteric monitoring in human
carbamoyl phosphate synthetase389, redox sensitive global regulator in Staph. Aureus390,
and allosteric control of S1A serine proteases391. Formation of disulfide bonds depends
on three key factors392; the availability of a proximal partner cysteine with correct
geometry for disulfide formation, the pH of the local microenvironment (pH> pKa of the
cysteine thiols favors reactivity) and the redox state of the local microenvironment
(oxidizing conditions favor S-S bond formation). Since the likelihood of disulfide bond
formation is strongly influenced by local cellular conditions, specific cellular
compartments have evolved in both prokaryotes and eukaryotes to support this
phenomenon. In bacteria, disulfide bond formation mostly occurs in the periplasm393,
while in eukaryotes, disulfide bond breaking and making is most common in the
endoplasmic reticulum (ER)392,394,395. The cytosol, being a more reducing environment
compared to the ER, rarely facilitates disulfide bond formation, although there are
exceptions. We discuss one such exception in Chapter 5, where the Isocyanide Hydratase
(ICH) enzyme from Ralstonia sp. contains two non-catalytic cysteines, Cys147 and
Cys220 which form disulfide bonds despite ICH being a non-ER protein.
Protein disulfide isomerase (PDI) is a family of endoplasmic reticulum (ER)
enzymes that oxidize cysteine thiols, which then form disulfides with other nearby
cysteines364,373,396–398. Extensive reviews have covered the topic of formation of disulfide
bonds, the enzymes involved, and their mechanisms in both prokaryotes and
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eukaryotes364,373,399–403. Even though the biochemistry of disulfide bond formation is well
described, there is comparatively little known about the process of regulated disulfide
bond reduction in the ER of mammals. Currently, there are no known PDI reductases or a
glutathione reductases in the ER to reduce the disulfide bonds364,404. In contrast to
mammals, the bacterial periplasmic reductive mechanism of disulfide breaking is very
well characterized364,405–407.
B) Sulfenic, Sulfinic, Sulfonic acid formation: Oxidation of the sulfur atom in cysteine
results in the formation of a series of organosulfur acids with progressively increasing
oxidation states; they are cysteine sulfenic, sulfinic and sulfonic acids respectively408–410
(Fig. 1).
Sulfenic acids are reactive, unstable oxyacids generated as a result of oxidation of
cysteine thiols (R-SH/RS-) with oxidants such as H2O2 359,410–414, alkylhydroperoxides
and peroxynitrites359,411. They may also form as a result of oxidation of the cysteine with
molecular oxygen, catalyzed by the cysteine dioxygenase enzyme415. These transient
compounds can exhibit both electrophilic as well as nucleophilic characteristics416; they
can react with neighboring thiols to form disulfides359,416,417 (Reaction III) or with
nitrogen nucleophiles to generate the rarer sulfenamides410,418–421. Sulfenic acids (R-SOH)
can be converted back to thiol (R-SH) by Thioredoxins (Trx)410 or other disulfide-based
reduction strategies involving transient glutathionylation followed by reduction. In the E.
coli periplasm, several proteins possess cysteine residues which form disulfide bonds. In
periplasmic proteins with single cysteines (lacking disulfide bond forming partner), these
residues are protected against oxidation to sulfenic, sulfinic and sulfonic acids by two
thioredoxin related proteins, DsbG and DsbC422.
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Sulfenic acids may also self-condense to form thiosulfinates359,423 (Reaction IV).
Since these sulfenic acid derivatives are also unstable, they have proven difficult to
isolate and study359,424,425.
2 R-SOH + R-SH→ R-S-S-R +H2O

………………………….

2 R-SOH→ R-S(O)-S-R +H2O

……………………….

(III)

(IV)
Table 1 of Lo Conte and Carroll’s review 410 contains a list of biologically important
proteins that form cysteine sulfenic acids and the authors discuss the regulatory
implication of some of these sulfenic acids in cellular signaling 426–429. Protein tyrosine
phosphatases420,421,430, cysteine proteases, papain, and glyceraldehyde-3phosphate347,359,410,425, NADH oxidases and peroxidases, peroxiredoxins431, glutathione
reductases, and human serum albumin (HA) are all regulated by sulfenylation412,432,433.
Other examples include the reversible oxidation of key cysteine-S- residues in
transcription factors Fos and Jun (activator protein 1) and bovine papillomavirus1 E2
protein, which inhibits DNA binding in response to intracellular redox sensing359,425.
Sulfenic acid formation also helps in CD8+ T cell activation and proliferation434. Roos
and Messens’ review 435 presents some of the most important biological roles of sulfenic
acids in living systems.
Sulfenic acids can be further oxidized to more stable sulfinic acids (R-SO2H)
(Table 2 of Lo Conte and Carroll’s review 410). Some examples of biologically relevant
proteins whose functions are mediated by formation of sulfinic acids, include
peroxiredoxins359,436–438, peroxidase (Prx)437, DJ-1 439–442, and hydratases (Nitrile
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Hydratase, SCNase) 410,443,444. Inactivation of peroxiredoxins by the formation of Cyssulfinic acids438 can be reversed by the ATP-dependent enzyme Sulfiredoxin445–450, 451,452.
Sulfinic acids can be further oxidized to form the most oxidized form of cysteine in
proteins, sulfonic acid (R-SO3H). An example of possible biological relevance of
cysteine sulfonic acids is found in the peroxiredoxins, which converts to a dodecameric
oligomer that exhibits enhanced chaperone activity when the active site cysteine to
oxidized to the sulfonate, although the relevance of this activity is debated453,454.
Protein tyrosine phosphatases (PTPs) catalyze the dephosphorylation of
phosphotyrosine in proteins455. PTPs are redox regulated by oxidation of the catalytic
cysteine, which abrogrates enzyme activity456–458. While sulfenic acid can be easily
reduced, reduction of the more stable sulfinic acid requires the dedicated sulfiredoxin
enzyme and sulfonic acids cannot be reduced under intercellular conditions421. The
oxidized cysteine in PTP, however, is capable of forming a sulfenyl-amide (-SN-) bond
with the nitrogen atom in the polypeptide backbone, thereby protecting the cysteine from
further oxidation455,459. Protein tyrosine kinase (PTK) can also be regulated by ROS and
oxidative stress conditions. PTKs in the Src and Fibroblast Growth Factor Receptor
(FGFR) families are inactivated in response to oxidation of their reactive cysteine
(Cys277)460. The epidermal Growth Factor Receptor (EGFR) family of receptor tyrosine
kinases mediate several important biological functions in the body, such as growth,
differentiation, proliferation, protection from cancers. Activation of EGFR results in
generation of ROS (H2O2), which in turn, oxidizes cysteine residues within redox
sensitive proteins. Moreover, EGFR itself is regulated via oxidation of its active site
Cys797461.
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The thioredoxin (TRX) and Nucleoredoxin (NRX) family of proteins undergo
similar redox regulation as PTPs, by virtue of their reactive cysteines455. TRX is the
archetypal thiol-disulfide oxidoreductase whose reversible disulfide formation is essential
for its catalytic activity as a thiol reductant. In addition to its primary role in maintaining
redox homeostasis, the oxidation of the cysteine pair 462,463 in TRX to form
intramolecular disulfide bonds causes its disassociation from the enzyme Apoptosis
signal regulating kinase 1 (ASK1)349. TRX is an inhibitor of ASK1, and its oxidationregulated dissociation activates ASK1 to induce ROS and apoptosis455,459,464,465. NRX
negatively regulates Wnt signaling by binding to and inhibiting DvI (dishevelled), which
is an essential adaptor protein involved in Wnt signaling 466. When the catalytic cysteine
pair in NRX is oxidized, binding to DvI is abolished and Wnt signaling is promoted,;
therefore, NRX plays a redox responsive role in mediating DvI activity similar to the
TRX/ASK1 interaction455,467–470.
Another protein family with prominent roles in intracellular redox signaling is the
peroxiredoxin (PRX) family of proteins. These proteins reduce hydrogen peroxide to
water simultaneously with the oxidation of a reactive cysteine (peroxidatic cysteine, CP)
to sulfenic acid (CP-SOH), which then reacts with another cysteine (resolving cysteine,
CR) to form a disulfide bond471. Depending on the presence or absence of the CR, PXS
enzymes can be classified into 2-Cys or 1-Cys PRX subfamilies472–474. Oxidized 2-Cys
PRX is then reduced and recycled by the TRX system and 1-Cys PRXs by glutaredoxin
474–476

. Under conditions of high oxidative stress, PRX forms homo oligomers which bind

and activate mammalian Ste20 like kinase 1 (MST1), leading to cell death and
apoptosis455,477–479. Irreversible oxidation of PRX cysteines into the hyperoxidized
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sulfinic and sulfonic acid forms inactivates PRX and serves as a cellular marker for
oxidative damage454.
Cysteine oxidation has consequences in energy metabolism as well.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a critical glycolytic enzyme, can
be oxidized at its active site cysteine residue to form a sulfenic acid or mixed disulfides
with glutathione or other proteins. This oxidation prevents glycolysis and perturbs energy
homeostasis and glucose metabolism349,480,481. Therefore, proteins containing reactive
cysteine residues can be modified by a range of electrophilic species produced by
metabolism or stress and thus can participate in multiple biochemical and signaling
pathways.
C) Other thiol oxidation processes: In addition to ROS, cysteine thiols (R-SH) are
oxidized by glutathione (S- glutathionylation: S-SG) and nitric oxide (S- nitrosylation: SNO) (Fig. 1).
S- nitrosylation is the process of covalent attachment of nitric oxide (NO) group
to a cysteine thiol (R-SH) group to form a cysteine-nitosothiol (R-SNO) 482–484.
Nitrosylation has emerged as an important redox regulatory mechanism for mediating
cGMP-independent NO signaling effects 485–487 as well as for combating nitrosative
stress486,488.
Cys-nitrosothiols (R-SNO) are involved in multiple biological processes489,
including apoptosis447, cardiovascular signaling485,490, combating cold stress in plants491,
HIV-1 protease inactivation492, transient receptor potential (TRP) channel activation493,
ion channel regulation, signal transduction, neurotransmission, DNA repair, etc489. In
protein tyrosine phosphatase 1B (PTP1B), S-nitrosylation inhibts irreversible oxidation
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of the catalytic cysteine (Cys215) into sulfinic and sulfonic acid species, thereby
protecting the enzyme from irreparable oxidative damage487. S-nitrosylation has also
been implicated in defense against microbial infections and cancer494. An excellent
account of the biological functions of cysteine nitrosothiols is available in Broillet’s
extensive review489.
Glutathionylation of cysteines is another mechanism by which cysteinecontaining proteins/enzymes act as redox signal transduction switches495,496. Cysteine
sufenic and sulfinic acids can be enzymatically (glutathione-s-transferases, glutaredoxins)
or non-enzymatically reduced and conjugated to glutathione (GSH) to form Sglutathionylated cysteines497 (Fig.1). Under conditions of nitrosative stress, cysteines can
be nitrosylated, as discussed previously; the nitrosothiols can then be converted into Sglutathionylated cysteines with or without S-nitrosoglutathione (GSNO) as a reaction
intermediate497 (reactions V-VII).
PS-N = O+ GSH→ P-S-S-G +HNO

…………………………. (V)

PS-N = O+ GSH→ PSH + GSNO

…………………………. (VI)

PSH + GSNO → P-S-S-G +HNO

…………………………. (VII)

Inside a cell, the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) is
known as the GSH/GSSG ratio which informs on the redox capacity or balance of the
cell. This balance is kept in check by redox reactions catalyzed by oxidoreductases such
as GSH peroxidase and GSH reductase. Disturbance of the GSH/GSSG ratio by increased
concentrations of ROS and RNS results in several pathological conditions such as
apoptosis and necrosis497. Proteins that undergo S-glutathionylation are typically
cytoskeletal, glycolytic, or involved in energy metabolism, signaling pathways, calcium
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homeostasis etc497. Some of the signaling pathways impacted by glutathionylation of
reactive cysteines include mitogenic signaling pathways (Ras MEK ERK pathway, PTPs,
Protein kinase A)498–501, PI3K signaling498,502–505, I κB kinase-nuclear factor κB
pathway497,506–508, pro apoptotic JNK-c-Jun pathway in cancer cells497,506,509–517.
Townsend et al. provide a detailed review of the biological and physiological mechanistic
impact of cysteine glutathionylation497. Redox regulation of mitochondrial functions by
glutathionylation of mitochondrial proteins and their effect on energy metabolism is
comprehensively reviewed by Mailloux et al518.
3.2.c) Other cysteine modifications:
Other cysteine modifications include metal-mediated modifications and
desulfurization (removal of cysteine thiol, including oxidative elimination of cysteine to
form dehydroalanine (DHA)519. These type of cysteine modifications are reviewed by
Chalker et al 65.
3.3. Cysteine covalent modification and internal enzyme dynamics:
Covalent modification is a common and physiologically important perturbation to
proteins. Reactive residues such as cysteine are prone to diverse covalent modifications
with catalytic or regulatory consequences. In the work described in this thesis, charge
neutralization of the reactive Cys101thiolate in Isocyanide hydratase (ICH) enzyme
triggers active site helical dynamics important for efficient substrate catalysis. The
cysteine modification in ICH remodels active site H-bonding networks and gates
catalytically important changes in protein dynamics with a clearly defined mechanism. It
is very common for protein structures to fluctuate owing to thermal motion and in
response to functional changes such as ligand binding. As a consequence, it is
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challenging to determine which protein motions are functionally most important at
equilibrium. Enzymes that are transiently and covalently modified during catalysis offer a
way to identify functional motions, as the modification can trigger catalytically important
conformational changes. The covalent modification of the active-site cysteine in
isocyanide hydratase weakens a critical hydrogen bond required for reactivity. Hydrogen
bond disruption triggers a cascade of conformational changes whose modulation by
mutation is detrimental to enzyme turnover. Most enzymes that form catalytic
intermediates will experience similar transient changes in active-site electrostatics,
suggesting that modification-gated conformational dynamics is common in enzymes.
Notably, all cysteine thiolates will experience a similar loss of negative charge upon
covalent bond formation. Because cysteine residues can have multiple roles in a protein,
including acting as a catalytic nucleophile, metal ligand, acylation target, redox target,
and others, many different modification-mediated signals may be transduced through
altered cysteine electrostatics to impact protein dynamics and function. Thus, cysteine
can potentially significantly expand the ways in which protein biophysical properties are
coupled or respond to cellular needs.
Enzymes catalyze biochemical reactions by binding, conformationally organizing,
and lowering the activation energy barrier of reactants 520. Aside from accelerating
certain biochemical reactions, enzymes also inhibit undesired, off-pathway reactions
involving highly reactive intermediate species521. The collective dynamics of enzyme and
substrate are often tightly coupled to the catalytic cycle 521–525. For example, substrate
binding can shift the enzyme’s conformational distribution to structurally and
electrostatically re-organize the active site. More controversially, the coupling of
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conformational dynamics and electrostatics has been proposed to directly contribute to
the chemical step of enzyme catalysis, although their precise roles remain actively
debated256,264,523,526–529 . Formation of catalytic intermediates transiently modifies the
enzyme and may lead to a new protein motion regime that facilitates later steps of
catalysis. These motions often span vastly different time-scales, from fs-ns for barrier
crossing to ms or longer for product release. While functionally important motions may
be present even in a resting enzyme530 , distinguishing functional motions from the many
other fluctuations of a macromolecule at equilibrium is challenging523, leaving major
questions about the role of dynamics in catalysis unanswered. For example, how do
catalytic intermediates reorganize an enzyme’s conformational landscape to facilitate
later steps in the catalytic cycle? Integrating recent developments in serial and
conventional RT crystallography with advanced computational methods531 can offer new,
exciting opportunities to reveal enzyme mechanism and interrogate the consequences of
cysteine modification on protein dynamics.
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CHAPTER 4:

Mix and Inject Serial Femtosecond Crystallography at XFEL reveals gated
conformational dynamics during ICH catalysis.

Note: The results described in this chapter have been published, all text is modified from the
original version “Mix-and-inject XFEL crystallography reveals gated conformational dynamics
during enzyme catalysis”.
https://doi.org/10.1073/pnas.1901864116

The catalytic cycle of ICH.
Isocyanide substrate binds with ICH Cys101-S− poised for nucleophilic attack and with the Cys101-Ile152 H-bond intact.
Formation of the thioimidate intermediate weakens the Cys101-Ile152 H-bond and causes helical motion (magenta helices
H and I) that promotes intermediate hydrolysis (red sphere; curved arrow). Hydrolysis of the thioimidate intermediate
restores the reactive C101-S− and strengthens the Cys101-Ile152 H-bond, favoring the strained helical conformation.
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4.1 Abstract:
How changes in enzyme structure and dynamics facilitate passage along the
reaction coordinate in catalysis is a fundamental, unanswered question. Here, we use
time-resolved, Mix-and-Inject Serial Crystallography (MISC) at an X-ray Free Electron
Laser (XFEL), ambient temperature X-ray crystallography, mutagenesis and enzyme
kinetics to characterize how covalent catalysis modulates isocyanide hydratase (ICH)
conformational dynamics throughout its catalytic cycle. We visualize this previously
hypothetical reaction mechanism, directly observing formation of a thioimidate covalent
intermediate in microcrystals during catalysis. ICH exhibits a concerted helical
displacement upon active-site cysteine modification that is gated by changes in hydrogen
bond strength between the cysteine thiolate and the backbone amide of the highly
strained Ile152 residue. These catalysis-activated motions permit water entry into the ICH
active site for intermediate hydrolysis. Mutations at a Gly residue (Gly150) that modulate
helical mobility reduce ICH catalytic turnover and alter its pre-steady-state kinetic
behavior, establishing that helical mobility is important for ICH catalytic efficiency.
These results demonstrate that MISC can capture otherwise elusive aspects of enzyme
mechanism and dynamics in microcrystalline samples, resolving long-standing questions
about the connection between nonequilibrium protein motions and enzyme catalysis.
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4.2. Introduction:

Protein dynamics play an important role in enzyme catalysis523–525,532. Many
enzymes form covalent catalytic intermediates that can alter enzyme structure and
conformational dynamics269,533–535. Because catalytic intermediates transiently modify
enzymes, they may activate a new protein motion regime that facilitates later steps of
catalysis. Determining how these transient changes in enzyme structure and dynamics
facilitate passage along the reaction coordinate is a topic of intense interest in structural
enzymology 525,535. Of all amino acids in proteins, reactive cysteine residues are subject
to the most diverse set of covalent modifications348,536. Moreover, the targeted
modification of cysteine residues proximal to active sites has become a frontline strategy
for the development of covalent enzyme inactivators as tools for chemical biology and
drugs537. Therefore, understanding how the H-bonding environment of active-site
cysteine residues modulates their reactivity and how the covalent modification of
cysteine thiolate anions controls protein conformational dynamics can provide general
insights into the functions of many proteins whose activities require or are regulated by
covalent modifications.
X-ray crystallography provides an atomically detailed ensemble and timeaveraged view of protein conformational dynamics in the lattice environment538–541.
Technological advances in X-ray sources, detectors, and sample delivery have enabled a
new class of crystallography experiments that report on nonequilibrium protein motions
in response to external perturbations542. Because these perturbations can be selected for
functional relevance (e.g., by the infusion of substrate or induction of a particular
modification), the resulting nonequilibrium changes often correspond to functionally
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important protein motions. In parallel, advances in computer modeling of multiple
conformational substates now enable visualizing minor populations of crystalline protein
structural ensembles. These approaches have permitted identification of networks of sidechain disorder543, allowed refinement of whole-protein ensemble models544, aided
identification of minor binding modes of therapeutic ligands545, and characterized spatial
correlations in protein mobility546.
The enzyme studied here is isocyanide hydratase (ICH; EC 4.2.1.103)
(PDB:3NON), a homo-dimeric cysteine-dependent enzyme in the DJ-1 superfamily that
irreversibly hydrates a wide range of isocyanides to yield N-formamides32(Fig. 1A). Prior
crystallographic studies of ICH showed evidence of helical mobility near the active-site
cysteine101 residue (Fig. 1C), which coincided with photooxidation of C101 to sulfenic
acid (C101-SOH)31. C101 accepts an S−-HN hydrogen bond from the severely strained
(φ = 14°, ψ = −83°) backbone amide of Ile152. When this hydrogen bond is disrupted in
an engineered C101A mutant (Fig. 1C), Ile152 relaxes to an unstrained backbone
conformation concomitant with displacement of the helix31,547.
The relevance of these motions for ICH function was not established in these
prior studies. Here, we use X-ray crystallography, molecular dynamics simulation,
mutagenesis, and enzyme kinetics to characterize a set of correlated conformational
changes that remodel the ICH active site and propagate across the dimer interface in
response to cysteine modification. Using time-resolved mix-and inject serial
crystallography (MISC) at an X-ray free electron laser (XFEL), we directly observe
formation of a covalent intermediate and transient, functionally important motions during
ICH catalysis. Pre-steady-state kinetics of wild-type and mutant ICH suggests that
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cysteine-gated conformational changes are important for water to access and hydrolyze
the catalytic intermediate. The prominence of conformational dynamics in ICH and the
tractability of this protein using multiple biophysical techniques make ICH a valuable
model system for understanding how cysteine modification can modulate functional
protein dynamics.
4.3 Materials and Methods:
Crystallization, data collection, and processing: Pseudomonas fluorescens ICH
enzyme was expressed from pET15b constructs in E. coli BL21DE3 cells as a thrombincleavable, N-terminally 6xHis-tagged protein and purified as previously described31. The
G150A and G150T mutants were made by site directed mutagenesis using mutagenic
primers and were verified by DNA sequencing (Eurofins). All of the final proteins
contain the vector-derived amino acids “GSH” at the N-terminus. Wild-type ICH, the
G150A, and the G150T mutants were crystallized by hanging drop vapor equilibration by
mixing 2 μL of protein at 20 mg/ml and 2 μl of reservoir (23% PEG 3350, 100mM TrisHCl, pH 8.6, 200 mM magnesium chloride and 2 mM dithiotheritol (DTT)) and
incubating at 22°C. Spontaneous crystals in space group P21 appear in 24-48 hours and
were used to micro-seed other drops after 24 hours of equilibration. Micro-seeding was
used because two different crystal forms of ICH crystals grow in the same drop and those
in space group P21 are the better-diffracting crystal form. Notably, seeding G150T ICH
using wild-type ICH crystals in space group P21 results exclusively in G150T crystals in
space group C2 with one molecule in the asymmetric unit (ASU).
Cryogenic (100K) synchrotron data (PDB 3NON) were collected at the Advanced
Photon Source beamline 14BM-C from plate-shaped crystals measuring ~500x500x150
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μm that were cryoprotected in 30% ethylene glycol, mounted in nylon loops, and cooled
by immersion in liquid nitrogen as previously described31. Ambient temperature (274 K
and 277 K) synchrotron data sets were collected at the Stanford Synchrotron Radiation
Lightsource from crystals mounted in 0.7 mm diameter, 10 μm wall thickness glass
number 50 capillaries (Hampton Research) with a small volume (~5 μl) of the reservoir
to maintain vapor equilibrium. Excess liquid was removed from the crystal by wicking,
and the capillary was sealed with beeswax. For the 274 K dataset, the crystal was
mounted with its shortest dimension roughly parallel to the capillary axis, resulting in the
X-ray beam shooting through the longest dimensions of the crystal during rotation. For
the 277 K dataset, a large single capillary-mounted crystal was exposed to X-rays and
then translated so that multiple fresh volumes of the crystal were irradiated during data
collection. This strategy reduces radiation damage by distributing the dose over a larger
volume of the crystal. This translation of the sample was factored into the absorbed dose
calculation by assuming every fresh volume of the crystal received no prior dose, which
is a best-case scenario.
The 100 K and 277 K datasets were collected on ADSC Q4 CCD detectors using
the oscillation method. Separate low- and high-resolution passes were collected with
different exposure times and detector distances and merged together in scaling, as the
dynamic range of the diffraction data was larger than that of the detector. For the 274 K
data, a Pilatus 6M pixel array detector (PAD) was used with shutterless data collection.
Because of the very high dynamic range of the detector, a full dataset was collected in a
single pass ~5 minutes. The 274 K datasets were indexed and scaled using XDS548 while
the 277K datasets were indexed and scaled and HKL2000549. The 100 K dataset was
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processed as previously described 31. See Tables 2-3 for Crystallographic data refinement
statistics.
Microcrystal growth and XFEL sample delivery. For the XFEL experiment,
microcrystals of ICH (~10-20µm) were grown by seeding. Initial seeds were obtained by
pulverizing macroscopic crystals via vortexing with 0.5 mm stainless steel balls for 5
minutes. A dilution of this seed stock was added to 31% PEG 3350, 250 mM MgCl2, 125
mM Tris-HCl pH=8.8 and then an equal volume of 40 mg/ml ICH was added and rapidly
mixed. The dilution of the seed stock dictated the final size of the microcrystals and was
optimized to produce crystals measuring ~20 μm x 20 μm x 2 μm. The mixture was
incubated at room temperature with shaking for ~20 minutes until microcrystal growth
stopped.
Samples were delivered to the beam using the concentric-flow microfluidic
electrokinetic sample holder (coMESH) injector550 under atmospheric pressure conditions
at room temperature and under normal atmosphere. The sample was loaded in a custom
stainless steel sample reservoir. A Shimadzu LD20 HPLC pump hydraulically actuated a
teflon plunger to advance the sample slurry. A stainless steel 20 µm frit filter (IDEX-HS)
was placed after the reservoir in order to ensure smaller crystal sizes and mitigate
clogging. The reservoir and filters were connected to the coMESH via a 100 µm x 160
µm x 1.5 m fused silica capillary (Molex). This capillary continued unobstructed through
the center of the microfluidic tee (Labsmith) and terminated at 0 mm, 2 mm, or 200 mm
recessed from the exit of a concentric 250 µm x 360 µm capillary, corresponding to Free
(Apo), 15 s and 5 min time delays, respectively. The capillaries were optically aligned to
obtain a 0 offset, then were recessed and measured externally to achieve the 2 mm and
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200 mm recess. In the case of the longer 200 mm offset, an additional tee (IDEX-HS)
was added to increase the length. The outer line of the coMESH flowed the stabilizing
solution (31% PEG 3350, 250 mM MgCl2, 125 mM Tris-HCl pH=8.8) in the case of the
Free (Apo) structure and flowed ~2 mM p-NPIC substrate in stabilizing solution for the
15 s and 5 min timepoints. DTT was omitted from all solutions as p-NPIC is not stable its
presence and the p-NPIC substrate was at saturation (estimated concentration is ~2 mM)
in this solution. The p-NPIC substrate was loaded into a 500 or 1000 µL gas tight syringe
(Hamilton). The stainless steel, blunt tip removable needle was connected to a 250 µm x
360 µm x 1 m fused silica capillary (Molex) and connected to the side of the coMESH
microfluidic tee junction for the APO and 15 s delay and into the side of the Idex tee for
the 5 minute delay. The syringe was driven by a syringe pump (KDS Legato 200) at 1-2
µl/min while being charged at 3.1 kV (Stanford Research Systems, SRS PS300) at the
wetted stainless-steel needle.
The outer liquid focused the fluids ~500 µm away from the outer capillary
towards the XFEL focus, of approximately 3 µm at the Macromolecular Femtosecond
Crystallography (MFX) end-station. The charged meniscus was approximately 5 mm
away from a grounded counter electrode to complete the electro kinetic focusing. The
time delays were assumed to be sufficiently long as compared to the electro kinetic
mixing phenomena and were determined simply by the time the bulk fluid would traverse
the offset distance. The flow rates and voltages were held constant during each time point
and the flow of the crystals were optically monitored with a 50x objective to assure
minimal flow deviations. For the APO (no delay) time point, the flow was 0.5 µl/min for
both the sample and outer flows. For the 15 s time delay, the capillaries were recessed 2
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mm, and the flows were 1 and 2 µl/min for the sample and p-NPIC flow rates,
respectively. The combined bulk flows (1+2 = 3 µl/min) and the 2 mm offset dictated the
delay time of 15 s. For the 5 min time delay, the capillaries were offset 200 mm and both
flow rates were held at 1 µL/min, for a combined bulk flow of 2 µL/min. Overall, ~0.5
mL of sample crystals and 0.5 mL of 3 mM p-NPIC were consumed to gather this data.
XFEL Data collection and Processing. Data were collected at the MFX endstation of
the Linac Coherent Light Source (LCLS). X-ray pulses were 9.5 keV, ~1x1012 photons
per 40 fs pulse at 30 Hz repetition. Beam size at sample was ~3 μm. Diffraction data were
collected on a Rayonix MX340-XFEL CCD detector operated in 4x4 binning mode and
hits were analyzed in real time using OnDA 269. The XFEL diffraction data were
processed with cctbx.xfel551, to identify 76,174 crystal hits for the Free (Apo)
data, 53,476 crystal hits for the 15 second delay data and 36,875 crystal hits for the 5
minute delay data. A small fraction of multiple lattice hits (<0.01% of total) were shown
to have little impact on data quality when included in the final post-refinement steps. For
the Free (Apo) data, 23,669 frames were indexed and 21,834 of those had their intensities
merged and integrated. For the 15s data, 26,507 frames were indexed and 24,286 of those
had their intensities merged and integrated. For the 5min data, 16,893 frames were
indexed and 14,483 of those had their intensities merged and integrated. To correct the
intensity measurements and merge the data, postrefinement was carried out with three
cycles of PRIME552 using model unit cell dimensions from a synchrotron wild type ICH
structure31. The Lorentzian partiality model used parameters gamma_e = 0.001,
frame_accept_min_cc = 0.60, uc_tolerance = 5, sigma_min = 2.5, and partiality_min =
0.2. The X-ray crystallographic data statistics for all datasets are provided in Tables 2-3.
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Selection of mix-and-inject X-ray time delays. We collected absorbance spectra of ICH
crystals in reservoir solution supplemented with 1mM p-NPIC and 40% glycerol using
UV-vis microspectrophotometry at SSRL BL 11-1 (Fig. 1B). We freeze-trapped the
reaction in the cryostream at fixed time-delays after adding substrate to the crystal before
collecting a spectrum. The p-NPIC absorption maximum is ~270 nm, while p-nitrophenyl
formamide product absorption maximum is ~315 nm on this instrument. The lack of an
isosbestic point suggests an intermediate accumulated. At a time delay of 15s, the
substrate peak at 270 nm had disappeared, while the product peak at 315 nm had not
formed yet. At 5 minutes, substrate is exhausted while the product peak at 315 nm had
fully formed, informing the timing for the XFEL experiment. The macroscopic (~2x106
μm3) crystals from which these spectra were collected were damaged by exposure to
substrate and did not diffract X-rays well after substrate was introduced, precluding a
cryotrapping X-ray diffraction experiment. In contrast, the microcrystals used for the
XFEL experiment (~2x103 μm3) were not damaged by substrate, necessitating a serial Xray crystallography approach.
Crystallographic model refinement. All refinements were performed in PHENIX1.9
against structure factor intensities using individual anisotropic ADPs and riding hydrogen
atoms553. Weights for the ADP refinement and relative weights for the X-ray and
geometry term were optimized. After convergence of the isotropic ADP refinements,
translation-libration-screw (TLS) refinements554 with automatic rigid body partitioning
were performed in PHENIX. For the C101-SOH and G150A ICH synchrotron datasets,
the alternate conformation for helix H (residues 148-173 in chain A) was modeled as a
single occupancy group, reflecting the presumed correlated displacement of sidechain
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and backbone atoms. Other disordered regions were also built into multiple
conformations manually in COOT555 if supported by 2mFo-DFc and mFo-DFc electron
density maps. Occupancies of these groups were refined but constrained to sum to unity
in PHENIX. Omit maps were calculated after removing the areas of interest from the
model and refining for three macrocycles. Final models were validated using
MolProbity556 and the validation tools in COOT and PHENIX. Model statistics are
provided in Table 3. Isomorphous difference maps (Fo(15s) – Fo(XFELAPO) and Fo(SR) –
Fo(XFELAPO)) were calculated using data to the lowest high resolution of the data sets,
1.55 Å. Structure factor data and refined coordinates are available in the Protein Data
Bank with the following accession codes: 6NI4, 6NI5, 6NI6, 6NI7, 6NI8, 6NI9, 6NJA,
6NPQ, 6UND, and 6UNF.
Evidence of ICH in-crystallo catalysis.. A single crystal of ICH was mixed with 1 mM
substrate, para nitrophenyl isocyanide (p-NPIC), incubated for the indicated times in
seconds (Fig. 1B), mounted and cryocooled to 100 K in a nitrogen cryo-stream.
Absorbance spectra were collected using the inline spectrophotometer at BL 11-1 at the
Stanford Synchrotron Radiation Lightsource (SSRL).
pH gradient wildtype ICH crystal growth, data collection and processing. For the pH
screen, crystallization buffers were made with 23% PEG 3350, 0.2 M MgCl2, 2mM DTT
and 0.1M Tris-HCl or 0.1M Na Acetate or 0.1M Na Citrate. Wildtype ICH was
crystallized by hanging drop vapor equilibration by mixing 2 μL of protein at 20 mg/ml
and 2 μl of the corresponding reservoir solution and incubating at 22°C. The drops were
streak seeded to facilitate the growth of the the better diffracting P21 space group.
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Synthesis of para-nitrophenyl isocyanide (p-NPIC). ICH will accept diverse
isocyanide substrates32. Due to its strong absorption in the visible range (λmax=320 nm),
para-nitrophenyl isocyanide (p-NPIC) was used here. The p-NPIC substrate is not
commercially available and was synthesized by the Dr. David Berkowitz and his group
(University of Nebraska Lincoln, Department of Chemistry) via dehydration of the Nformamide precursor. To synthesize N-(4-Nitrophenyl) formamide, a mixture of amine
(10 mmol) and formic acid (12 mmol) was stirred at 60 °C for 2h.

After completion of the reaction, as judged by Thin Layer Chromatography (TLC), the
mixture was diluted with CH2Cl2 (100 mL), washed with saturated solution of NaHCO3
and brine (100 mL), and then dried over anhydrous Na2SO4 and concentrated under
reduced pressure. The residue was dissolved in hot acetone and crystallized, to yield N(4-Nitrophenyl) formamide (1.58 g, 96%) as a yellow solid. The product was verified
using 1H NMR, 13C NMR, IR, and Time of Flight (TOF) mass spectra.
To synthesize p-Nitrophenyl isocyanide, the mentioned N-(4-Nitrophenyl)
formamide product (8.0 mmol) and triethylamine (56 mmol) were dissolved in
CH2Cl2 (30 mL) and cooled to -10 °C.
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A solution of triphosgene (8.0 mmol) in CH2Cl2 (50 mL) was slowly added and stirring
was continued at -10 °C for another 30 minutes. After completion of reaction (judged by
TLC), the reaction mixture was passed through a pad of silica gel and washed with
CH2Cl2. The filtrate was dried over anhydrous Na2SO4, and then concentrated under
reduced pressure. The residue was triturated with cold hexane to yield para-nitrophenyl
isocyanide (1.36 g, 92%) as a yellow solid. 1H NMR, 13C NMR, IR, and Time of Flight
(TOF) mass spectra were collected to verify the product structure. The para-nitrophenyl
isocyanide product was stored as a dry solid at -80°C
until needed.
ICH enzyme kinetics. Steady state ICH rate measurements were initiated by the addition
of ICH (final concentration of 1 µM) to freshly prepared p-NPIC solutions ranging from
0-60 µM in reaction buffer (100 mM KPO4 pH=7.0, 50 mM KCl, and 20% DMSO). pNPIC was diluted from a 0.5 M stock solution in dimethyl sulfoxide (DMSO), which was
stored at -80 °C and protected from light. A 200 µl reaction was maintained at 25 °C in a
Peltier-thermostatted cuvette holder. The formation of the product, para-nitrophenyl
formamide (p-NPF) was monitored at its absorption maximum of 320 nm for two
minutes using a UV-Vis Cary 50 Spectrophotometer (Varian, Palo Alto, CA). A linear
increase in A320 was verified and used to calculate initial velocities. Isocyanides can
spontaneously hydrolyze slowly in aqueous solutions, with the rate increasing as pH is
lowered. To ensure that all measured product formation was due to ICH catalysis, the rate
of spontaneous p-NPIC hydrolysis was measured without added ICH. These values were
near the noise level of the spectrophotometer and were subtracted from the raw rate
measurements before fitting the Michaelis-Menten model. The extinction coefficient at
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320 nm for p-NPF was determined by using ICH to convert known concentrations of pNPIC to p-NPF, followed by measuring the absorbance at 320 nm. The slope of the
resulting standard curve was defined as the extinction coefficient of p-NPF at 320 nm;
ε320=1.33x104 M-1 cm-1. This p-NPF ε320 value was used to convert the measured rates
from A320/sec to [p-NPF]/sec. All data were measured in triplicate or greater and mean
values and standard deviations were plotted and fitted using the Michaelis-Menten model
as implemented in Prism (GraphPad Software, San Diego, CA). Reported Km and kcat
values and their associated errors are given in Fig. 4E-F.
Pre-steady state ICH kinetics were measured at 25 ˚C using a Hi-Tech KinetAsyst
stopped flow device (TgK Scientific, Bradford-on-Avon, United Kingdom). Data were
collected for each sample for two seconds (instrument deadtime is 20 ms) in triplicate.
The final enzyme concentration after mixing was 10 M and final p-NPIC concentrations
were 20, 40, 80, 120, 160, and 320 M. Product evolution was monitored at 320 nm
using a photodiode array detector. Kinetic Studio software (TgK Scientific, United
Kingdom) was used to analyze the kinetic data and to fit a mixed model containing a
single exponential burst with a linear steady state component: -Aexp(-kt) + mt + C. In
this equation, t is time, k is the burst phase rate constant, m is the linear phase (steadystate) rate, A is the amplitude of the burst component, and C is a baseline offset constant.
The linear slope m was used to calculate steady state turnover numbers, which agree well
with kobs values obtained from steady state kinetic measurements at comparable substrate
concentrations. Single turnover experiments were also performed using final
concentrations of 40 M enzyme and 20 M p-NPIC after manual mixing. Spectra were
collected using a Cary 50 spectrophotometer (Varian, Palo Alto, CA, USA). Spectra
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were collected every 10 seconds with a deadtime of ~30 seconds after manual addition of
enzyme.
Isocyanide (p-NPIC) toxicity assays. E coli BL21DE3 cells bearing the ICH containing
pET15b recombinant plasmids were grown until OD600=0.5-0.6 at 37˚C and 250rpm
shaking, upon which they were induced with 0.5mM IPTG. 1 ml of induced cells were
mixed rapidly with 5mls of cooled autoclaved soft agar (0.8%) supplemented with
100mg/ml Ampicillin and poured over 1.5% LB agar plates and incubated at room
temperature (22-25˚C) for 1 hour. Once the soft agar had solidified, stress chemicals
were prepared fresh (500mM, 100mM and 10mM p-NPIC in 100%DMSO). Each LBA
plate was divided into four quadrants and sterile autoclaved filter discs (1 cm diameter)
were placed in the four sections. 10µl stress chemical was added to each disk and the
plates were incubated at 37˚C overnight. Diameters of the developed zone of clearances
were manually measured in triplicates after 24 hours and plotted as a function of substrate
concentration using Prism (GraphPad Software, San Diego, CA).
4.4 Results:
4.4.1 ICH actively catalyzes hydration of isocyanides to formamides in crystallo.
Prior to XFEL characterization of catalytic turnover of ICH, it is important to
ensure that the enzyme is active in the crystal form as a pre-requisite to the planned
XFEL MISC experiment. A single crystal of ICH was mixed with 1 mM p-NPIC,
mounted and cryocooled to 100 K in a nitrogen cryostream. Absorbance spectra were
collected using the inline spectrophotometer at BL 11-1 at the Stanford Synchrotron
Radiation Lightsource (SSRL). On this instrument, the p-NPIC substrate has an
absorption maximum of 270 nm and the p-NPF product has an absorption maximum of
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315 nm. Note the absence of an isosbestic point (Fig. 1B).
4.4.2 Formation of thioimidate reaction intermediate during ICH catalysis triggers
active site conformational dynamics in ICH.
Mix and Inject Serial Crystallography (MICS) at the LCLS XFEL at 298K allowed us to
examine the role of active site structural dynamics in ICH turnover by directly
monitoring catalysis in ICH microcrystals. We infused the substrate p-nitrophenyl
isocyanide (p-NPIC) into a stream of unmodified ICH microcrystals (Methods) and
collected diffraction data at carefully selected time delays (Fig. 1B). The concentration of
p-NPIC in the stream allowed only a single turnover of crystalline ICH before substrate
depletion. It is important to note here that due to the “diffraction before destruction”
principal, SFX data are minimally affected by X-ray radiation damage557, as a result of
which the enzyme suffered no radiation-induced oxidation of C101 (Fig. 1D). It is
essential to rule out radiation damage induced conformational switching in ICH from
catalysis induced dynamics because both events are triggered by C101 covalent
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Fig 1:(A) Hydration of isocyanides by ICH yields corresponding formamides. (B) In-crystallo ICH
turnover monitored in a single crystal mixed with 1 mM p-NPIC, mounted, cryocooled to 100 K in a
nitrogen cryostream. Absorbance spectra collected using the inline spectrophotometer at BL 11-1 at the
Stanford Synchrotron Radiation Lightsource (SSRL). (C) The ICH dimer is shown as an overlay of WT
ICH (purple) and C101A ICH (blue). The “B” protomer is shown in yellow. The mobile helix H in C101A
and areas exhibiting correlated backbone–side-chain disorder are rendered opaque. Ile152 is a
Ramachandran outlier (Inset) whose backbone torsion angles move with helical displacement.(D) ICH
completes a full catalytic cycle in the crystal during MISC. Helix H is shown with 2mFo-DFc electron
density (0.8 rmsd) prior to the introduction of substrate (blue) and after substrate has been exhausted
(orange). These maps overlap almost perfectly, indicating that ICH is fully restored to its resting
conformation after catalysis. The hydrogen bond between the peptide backbone of Ile152 and Cys101 is
shown in a dotted line. The helix is not mobile in these resting structures, indicated by the absence of
features in the mFo-DFc difference electron density (2.5 rmsd prior to substrate [green] and after catalysis
is complete [purple]) (E) MISC confirms that ICH forms a covalent Cys101-thioimidate intermediate 15 s
after substrate mixing. Difference mFo-DFc electron density contoured at 2.5 rmsd (green) supports
sampling of shifted helix H conformations upon intermediate formation. (F) Postulated reaction
mechanism for ICH, beginning with Cys101 thiolate attack at the electrophilic carbenic carbon atom of
isocyanide substrates and proceeding in the direction of the arrows. A previously postulated thioimidate
intermediate (red box) eliminates the charge on Cys101 and weakens the H-bond to Ile152 (dashed red
line). This relieves backbone torsional strain at Ile152 and permits sampling of shifted helix H
conformations (green curved arrow), allowing water access to the intermediate for hydrolysis.

modification. The proposed reaction mechanism of ICH (Fig. 1F). states that the
catalytic C101 nucleophile attacks organic isocyanides at the electron-deficient carbene-

84

like center, followed by proton abstraction from a nearby general acid to generate a
covalent thioimidate intermediate. An enzyme-linked thioimidate, which has not been
previously observed, eliminates the negative charge of the C101 thiolate (S−) and is
proposed to reduce the strength of the C101-I152 hydrogen bond.

Fig 2: Observation of thioimidate intermediate formation and enhancement of ICH helix
mobility. In (A), omit mFo-DFc electron density is shown at 3.0 rmsd (green) and 5.0 rmsd (purple),
unambiguously demonstrating presence of the catalytic intermediate. In (B-D), anisotropic atomic
displacement parameters (ADPs) from TLS models refined against the XFEL datasets are shown at the
75% probability level and colored according to Beq value, from blue (7 Å2) to red (30 Å2). Starting
with the resting enzyme before substrate is introduced (B), helical mobility is transiently elevated upon
thioimidate intermediate formation during catalysis (C) and then is reduced again upon completion of
catalysis (D) once substrate is consumed 5 minutes after mixing.

After 15 s of mixing with substrate, 2mFo-DFc (Fig. 1E) and omit mFo-DFc electron
density maps (Fig. 2A) unambiguously reveal the formation of a thioimidate covalent
intermediate in both ICH protomers. Once the intermediate is formed, positive mFo-DFc
difference electron density appears around helix H (Fig. 1E) and its B-factors increase
(Fig. 2B-D), indicating that it samples a new conformational ensemble. This difference
density and elevated B-factors are absent both prior to catalysis and after ICH has
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exhausted substrate 5 minutes after mixing (Fig. 1D, Fig. 2B-D). Therefore, helix H
becomes transiently mobile upon intermediate formation during ICH catalysis, changing
the active site microenvironment.

Fig 3: X-ray induced cysteine oxidation drives helical motion in ICH. (A-C) The top panels show
the environment of Cys101 with varying degrees of oxidation to Cys101-sulfenic acid. 2mFo-DFc
electron density is contoured at 0.7 RMSD (blue) and the hydrogen bond between the peptide backbone
of Ile152 and Cys101 is shown in a dotted line. “Cryo” is synchrotron data collected at 100 K (PDB
3NON), “RT less oxidized” is synchrotron data collected at 274 K with an absorbed dose of 2.4x10 4 Gy,
and “RT more oxidized” is synchrotron data collected at 277 K with an absorbed dose of 3.7x10 5 Gy.
The lower panels show helix H in its strained (black) and relaxed, shifted conformations (grey). 2mF oDFc electron density is contoured at 0.8 RMSD (blue) and omit mF o-DFc electron density for the shifted
helical conformation is contoured at 3.0 RMSD (green). At 274-277K, increased Cys101 oxidation
disrupts the hydrogen bond to Ile152 and results in stronger difference electron density for the shifted
helix conformation. (D) The refined occupancy of helix H for each X-ray dataset, indicating that
increases in temperature and Cys101 oxidation result in higher occupancy for the shifted (relaxed) helix
conformation. (E) Mechanism of X-ray induced covalent modification of C101 and weakening of the S —
-NH hydrogen bond. (F) Cys101 oxidation leads to a weakening of the Ile152-Cys101 H-bond.
Electrostatic Poisson-Boltzmann surfaces (red negative, blue positive charge) calculated from the
Cys101-Ile152 (A) and Cys-SOH-Ile152 (B) environments. Cysteine photooxidation neutralizes the
negative charge of the sulfur atom, weakening the N-H ..S hydrogen bond. We calculated a reduction in
the Cys101-Ile152 hydrogen bond energy from -2.2 kcal/mol under reduced conditions (i.e. with a
thiolate acceptor) to -0.91 kcal/mol upon Cys101-SOH formation.
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We reasoned that the on-pathway thioimidate intermediate weakens the interactions that
hold helix H in a strained conformation similarly to the X-ray-induced C101-SOH
modification in the resting enzyme. Consistent with this idea, the cryogenic dataset
collected at 100K (Cryo) also shows evidence of radiation-driven C101-SOH formation
and a corresponding increase in helical mobility31 (Fig. 3A). To enrich populations of the
conformational shifts, we therefore collected a series of X-ray diffraction data sets of WT
ICH at increasing doses of X-ray radiation (Fig. 3A-C). Two ambient temperature (274277K) synchrotron radiation datasets at 1.20-1.15 Å reveal a radiation-dose dependent
C101 oxidation and helical displacement with increasing occupancy (Fig. 3D). Refined
occupancies of alternate conformations of helix H confirm a population shift towards the
displaced helix position along this series of data sets that correlates with the extent of
absorbed X-ray dose and concomitant C101 oxidation. The shifted helix conformations
across data sets are highly similar, suggesting that the observed electron density features
result from coupling between this helix and specific, radiation-induced photochemistry at
C101.
Notably, these stronger density peaks correspond to the difference electron
density observed in the MISC experiment during ICH catalysis (Fig. 1E, Fig. 3A-C). In
the ambient temperature synchrotron radiation datasets, the helical shift is caused by
radiation-induced oxidation of the C101 eliminating the negative charge on Sγ thiolate
and thus weakening the hydrogen bond between the amide H of Ile152 and C101 Sγ,
from -2.2 kcal/mol with a thiolate acceptor to -0.91 kcal/mol with a C101-SOH acceptor
(Fig. 3E-F). Similar loss of C101 thiolate negative charge occurs in the on-pathway
thioimidate intermediate, which also weaken the C101-I152 hydrogen bond. (Fig. 1F).
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4.4.3 Cysteine modification-gated motions increase ICH catalytic efficiency
To modulate helical mobility and measure the impact on ICH catalysis, we
designed two mutations, G150A and G150T. G150 is part of a highly conserved diglycyl
motif that moves ~3Å to accommodate helical motion in ICH. Ambient temperature
(274-277 K) crystal structures of G150A and G150T ICH show that the added steric bulk
at this position biases the helix towards its relaxed conformation (Fig. 4A, B). In G150A
ICH, helix H samples both conformations in both protomers (Fig. 4A, C-D). By contrast,
the G150T structure shows helix H constitutively shifted to its relaxed position (Fig. 4B).
Both G150A and G150T have an alternate C101 sidechain conformation which conflicts
with the unshifted conformation of Ile152 and helix H (Fig. 4A-B asterisk), indicating
that the helix must move partially independently of C101 modification in these mutants.
As in wild-type ICH, G150A shows evidence of C101-SOH oxidation in the electron
density (Fig. 4A). In contrast, C101 in G150T ICH is not modified by comparable
exposure to X-rays (Fig. 4B), indicating that the Ile152-NH-C101-S- hydrogen bond is
important for enhancing C101 reactivity.
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Fig 4: (A-B) (Top). 2mFoDFc electron density is contoured at 0.7 rmsd (blue) and the H-bond appears as a dotted
line. Both G150 mutations permit unmodified Cys101 to sample conformations (asterisk) that sterically conflict
with Ile152 in the strained helical conformation (black), requiring the helix to sample shifted conformations (gray)
in the absence of Cys101 modification. (A and B, Lower) The helix in its strained (black) and relaxed, shifted
conformations (gray). 2mFo-DFc electron density is contoured at 0.8 rmsd (blue) and omit mFo-DFc electron
density is contoured at +3.0 rmsd (green).(C-D) Helical mobility is asymmetric in wild-type but not G150A ICH
The top panels show the environment of Cys101 in the second protomer (“protomer B”) of wild-type (WT) and
G150A ICH. 2mFo-DFc electron density is contoured at 0.7 RMSD (blue) and the hydrogen bond between the
peptide backbone of Ile152 and Cys101 is shown in a dotted line. The lower panels show the helix in its strained
(black) and relaxed, shifted conformations (grey). 2mFo-DFc electron density is contoured at 0.8 RMSD (blue) and
omit mFo-DFc electron density for the shifted helical conformation is contoured at 3.0 RMSD (green). Wild-type
ICH does not show strong evidence of a second conformation, even though Cys101 has been partially
photooxidized to Cys101-SOH (top). In contrast, the helix in monomer B of G150A ICH shows strong evidence of
a second, relaxed conformation, similar to monomer A. Steady-state (E) and pre-steady state (F) enzyme kinetics of
wild-type (WT; blue circles), G105A (black squares), and G150T (red triangles) ICH. Both the G150A and G150T
mutations result in similar decreases in steady-state kinetics compared to WT enzyme. (E) The burst rate constant
in pre-steady state kinetics is linearly dependent on substrate concentration. This linear dependence indicates a
second order rate process during the burst phase, consistent with thioimidate intermediate formation. WT and
G150A have similar second order burst rate constants (G) Pre-steady-state enzyme kinetics of WT (blue circles),
G105A (black squares), and G150T (red triangles) ICH at 160 μM p-NPIC shows a pronounced burst phase for
each protein with differing burst and steady-state rate constants. (H) Single-turnover spectra of ICH enzymes with
p-NPIC substrate shown from early (red) to later (blue) timepoints in 5-s increments. At early times, G105A and
G150T accumulate a species with λmax = 335 nm, likely the thioimidate intermediate that resolves to product in the
blue spectra with λmax = 320 nm. (I) The catalytic cycle of ICH (Summary figure).
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Unlike the C101A mutant, which shows similar helical displacement but is
catalytically inactive, G150A and G150T ICH are catalytically active. This allowed us to
investigate the role of helical displacement in the ICH catalytic cycle. Steady-state
enzyme kinetics of the G150A and G150T mutants measured using p-NPIC as the
substrate show a ~6–fold reduction in kcat for both mutants compared to wild-type
enzyme but largely unchanged KM values (Fig. 4E, F Table 1). In contrast to their similar
steady-state kinetic behavior, the G150 mutants have divergent pre-steady state kinetic
profiles in stopped-flow mixing. ICH exhibits “burst” kinetics (Fig. 4G), indicating that
the rate-limiting step for ICH catalysis comes after formation of the thioimidate
intermediate. G150A ICH has a burst exponential rate constant k of ~11 s-1 that is
comparable to the wild-type enzyme, but G150T has a reduced burst rate constant of ~4 s1

, indicating a slower chemical step (Fig. 4E-G, Table 1). WT and G150A ICH have

comparable second order rate constants for the burst phase, while G150T is markedly
lower (Fig. 4E-F, Table 1). In addition, the burst amplitude of G150A is approximately
twice as large as that of the wild-type ICH despite equal concentrations of enzyme (Fig.
4G), which correlates with both protomers of G150A having a mobile helix H compared
to only one protomer of wild-type ICH (Fig. 4C-D). This suggests communication
between the two active sites in the ICH dimer that is dynamically gated by helix H.
Although both the G150A and G150T mutations impair ICH catalysis, the kinetic effect
of the G150A mutation is predominantly in steps after formation of the
intermediate, while G150T impairs both the rate of intermediate formation and later, ratelimiting steps. Thus, modulation of helical dynamics by the G150A and G150T mutants
have divergent effects on ICH catalysis, indicating that the active site helical switching is
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essential to support efficient ICH catalysis. Furthermore, we observe spectral evidence
for the thioimidate intermediate in single-turnover UV-visible spectra (Fig. 4H). G150A
ICH accumulates a species whose absorbance maximum is 335 nm, while WT ICH
completes a single turnover and accumulates the 320 nm formamide product in the ~30
second deadtime of manual mixing (Fig. 4H). G150T ICH accumulates less of the 335
nm intermediate than G150A ICH due to a closer match between the rates of formation
and consumption of the intermediate in G150T ICH. In G150A ICH, the 335 nm species
slowly converts to the 320 nm product over ~40 s, consistent with the slow rate of
product formation observed after the burst in G150A pre-steady state kinetics (Fig. 4G).
These data support the conclusion that the 335 nm species is the ICH-thioimidate
intermediate observed in the MISC experiment and that G150A is impaired in
hydrolyzing this covalent intermediate from the active site C101 due to perturbed
dynamics of helix H. It will be interesting to use the lower G150A mutant ICH in a
similar MISC experiment at LCLS at ambient temperature to potentially trap the other
reaction intermediate (tetrahedral) during IC
The impaired catalytic effects of the G150A and T mutations can also be demonstrated in
in vivo p-NPIC toxicity assays performed with E.coli BL21DE3 cells bearing the pET15b
constructs (Fig. 5A-D). BL21DE3 cells expressing the catalytically dead enzyme C101S
was used as negative
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Fig. 5: (A-C) LBA plates showing zones of clearances in wtICH, G150T and G150A respectively, in
response to varying doses of isocyanide p-NPIC (DMSO vehicle control, 10mM, 100Mm, 500mM pNPIC). (D) Diameters of the zones of clearances formed by E. coli BL21DE3 cells bearing the various
ICH-pET15b constructs linearly track the concentration of the stress chemicals

control and pET15b only cells were used as the empty vector controls. DMSO vehicle
controls were included in each run (n=3). Fig. 5 clearly demonstrates the loss of
isocyanide (p-NPIC) remediation abilities in BL21DE3 cells expressing G150A and
G150T (Fig. 5B-C) compared to wildtype ICH bearing cells (Fig. 5A) as seen by the
increased diameters of their zones of clearances (Fig. 5D).
4.4.4 Propagation of cysteine-gated conformational changes across the ICH dimer.
To characterize the extent of the conformational response of the entire ICH dimer to the

92

Fig. 6: (A) Isomorphous difference maps show widely distributed conformational changes upon
cysteine modification. Fo(SR) – Fo(XFELFree) (top panels) and Fo(XFEL15s) – Fo(XFELFree)
(bottom panels) difference maps are contoured at 2.75 rmsd. difference features (green, positive; red,
negative) are nonuniformly distributed in both maps, radiating out from the site of the catalytic
nucleophile (yellow spheres). This is more pronounced in the A protomer (slate blue) than the B
protomer (grey) in the Fo(SR) – Fo(XFELFree) map (top panels). Difference features generally show
the same, but weaker pattern in the Fo(XFEL15s) –Fo(XFELFree) map, where the 15 s timepoint
corresponds to thioimidate intermediate formation. The maps are phased with the Free (no substrate)
XFEL structure. (B) Isomorphous Fo(SR) – Fo(XFELFREE) difference map reveals broadly altered
structure and dynamics upon formation of the Cys101-SOH in the 274-K synchrotron radiation
(FoRT) dataset. Helices H and I are opaque in both conformers. The catalytic nucleophile is shown in
spheres. Difference electron density features are nonuniformly distributed, with stronger features near
helix H in the A protomer, and along region B169–B189, which contacts the N-terminal end of helix
H. Maps are contoured at ±3.0 rmsd. (C) CONTACT analysis identifies allosteric coupling across the
dimer interface, in striking agreement with isomorphous difference maps and rmsfs from (B). The A
protomer is color-coded in blue; the B protomer, in red. Residues identified in the CONTACT analysis
are projected onto the cartoon.

modification of C101, we calculated an Fo(SR) – Fo(XFELFree) isomorphous difference
map, phased with a structural model obtained from the XFEL data set. The Fo(SR) –
Fo(XFELFree) isomorphous difference map provides an unbiased view of differences in
molecular conformation between two data sets, reporting specifically on changes in ICH
that occur in response to oxidation of C101. A Fo(15s) – Fo(XFELFree) map calculated
using the thioimidate dataset after 15 s of mixing and the dataset prior to introduction of
substrate (Free) reveals similar features to those seen in the Fo(SR) – Fo(XFELFree) map
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(Fig.6A) signifying that the widespread dynamic response observed in Fo(SR) –
Fo(XFELFree) difference map is common to different types of C101 modification. We
further examined the dynamical communication across the dimer interface in ICH using
CONTACT network analysis of the electron density maps. CONTACT elucidates
pathways of collective amino acid main- and sidechain displacements through mapping
van der Waals conflicts that would result from sidechain conformational disorder if
correlated motions are not considered 543. CONTACT identified a large network of
correlated residues in protomer A (with the mobile helix) that connects with a smaller
network in protomer B (Fig. 6C), corroborating the isomorphous difference map. The key
residues in CONTACT analysis that bridge the dimer interface are Tyr181 and Thr153,
which are also key residues identified in the isomorphous difference map. Our results
indicate that the conformational changes upon C101-I152 H-bond modification in the
synchrotron structure correspond to later steps in the catalytic cycle, allowing helical
motion that facilitates intermediate hydrolysis and product release. At the same time,
increased allosteric transmission during these later steps may prime the dimer for the next
catalytic cycle. Ongoing work includes generation of Y181F and D157N mutants to
eliminate or weaken an intra-dimer hydrogen bonding between Y181 and D157 residues
to manipulate this dimer spanning allosteric network of corelated motions to better
elucidate its impact on ICH catalysis.
4.4.5 The charge on C101 in ICH modulates active site dynamics
pH can be used as a controlling parameter to modulate C101 gated active site
helical dynamics in ICH, independent of X-ray induced oxidation or catalysis. The
rationale behind this is, when the pH of the reservoir solution is lesser than the pKa of the
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C101, it is protonated. Therefore, the protonated (neutrally charged) C101cannot
effectively form the negative charge assisted H bond with Ile125, causing it to relax and
adopt an outlier conformation, triggering helical mobility. In this study, wildtype ICH
was crystallized at pH 4.2, 5.0, 5.4, 6.0 and 8.3 (Fig. 7). Upon optimization of pH in the
crystallization buffer, ICH shows varying degrees of C101 protonation/deprotonation and
corresponding helical mobility in both protomers.
At pH 4.2 and 5.0 (Fig. 7A-B), C101 is protonated and the Ile152 primarily
adopts a relaxed conformation, in contrast to pH 6.0 and 8.3 (Fig. 7D-E), where the C101
is deprotonated (negatively charged); the negative thiolate forms hydrogen bond with
Ile152, holding it in the restrained conformation. It is to be noted here that the pH 5.6 and
8.3 datasets show some positive density around the C101, indicating some oxidation of
the C101, which potentially contributes to the Ile152 relaxed conformation (negligible). It
would be beneficial to repeat these datasets, with properly handled crystal samples to
ensure there is no oxidation. pH 5.0 (Fig. 7C), shows a mixture of both protonated and
deprotonated C101 and a disordered active site with Ile152 occupying both restrained and
relaxed conformations. These studies conclude that when the C101 is negatively charged,
the negative thiolate can form H bond with Ile152 and hold it in the restrained
configuration, whereas when the C101 is neutral or uncharged, it cannot form H bond
with Ile152, releasing it to its relaxed configuration, triggering active site helical
dynamics. This work is important because it confirms that the helical dynamics in ICH
are dependent on the overall charge on the C101. It also shows that pH can be used as a
control parameter to tune the internal ICH active site motions, thereby making this
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enzyme an excellent model for the development of Diffuse Scatter (DS) data analysis and
processing methods.

Figure 7: pH can be used to control ICH helical motions (A) pH 4.2 and (B) pH 5.0 shows
protonated (uncharged) Cys101 and Ile152 shifted to relaxed configuration. (C) pH 5.0 shows a
mixture of protonated and deprotonated Cys101 and sampling of relaxed and restrained
configurations by Ile152. (D) pH 6.0 and (E) pH 8.3 show deprotonated Cys101 and Ile152
primarily occupying restrained configuration.

Diffuse scattering occurs from an imperfect or disordered crystal, when the scattering
amplitudes do not add up constructively as in Bragg diffraction. The amplitude of the
Bragg peak decreases and this lost intensity is redistributed into diffuse scattering. Thus,

96

DS has the potential to inform on corelated motions inside crystals, but technological
challenges prevent use of DS in protein crystallography. Currently there exist limited
tools to interpret and process DS data, as a result of which, the DS portion of datasets are
most often ignored when refining models. By manipulating the internal motions in ICH,
we can develop DS data analysis and processing methods.
4.5 Discussions:
Covalent modification is a common and physiologically important perturbation to
proteins. Reactive residues such as cysteine are prone to diverse covalent modifications
with catalytic or regulatory consequences. We found that cysteine modification in ICH
remodels active site H-bonding networks and gates catalytically important changes in
protein dynamics with a clearly defined mechanism. ICH catalyzes a reaction that can be
divided into an early phase dominated by nucleophilic attack of the reactive C101 at the
electrophilic carbenoid carbon of its isocyanide substrate and a later phase dominated by
water attack at the thioimidate and weaker nucleophilicity of C101 (i.e. a better leaving
group) to release the N-formamide product (Fig. 1F). Modification of the active site
cysteine thiolate upon formation of the thioimidate, during the first step of catalysis,
neutralizes its negative charge and weakens a key H-bond, activating correlated motions
that span the entire ICH dimer. After formation of the thioimidate, the helix samples the
shifted conformation due to weakening of the I152-C101 H-bond, dynamically
remodeling the ICH active site (Fig. 1F, Fig. 4I) and permitting water entry. This
transient remodeling is required for hydrolysis of the thioimidate intermediate, because
the active site containing the intermediate in occluded and does not contain room enough
for a water to enter without motion. Water attack at the C-S bond of the thioimidate is
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proposed to form a tetrahedral intermediate (Fig. 1F).At this point, the H-bond between
C101 and I152 that defines the strained conformation of helix H can reform, thereby
stabilizing the nascent C101 thiolate and making it a better leaving group, thereby
coupling dynamical changes in the enzyme to progress along the reaction coordinate (Fig.
4I).With the strained helical conformation restored, the product is released and leaves the
active site poised for another cycle of catalysis (Fig. 4I).
The divergent pre-steady state kinetics of the G150A and G150T mutants
suggest a model where the strained helical conformation of ICH has the highest
competence for the initial isocyanide attack by C101, forming the thioimidate
intermediate (Fig. 1E, Fig. 2A). This is also consistent with the diminished propensity of
C101 for photooxidation in G150T, where the helix is constitutively shifted, suggesting
that C101 is less reactive in this environment. The G150A/T mutants modulate helical
dynamics and thus allow us to determine if the non-equilibrium helical motions that we
observe in the thioimidate intermediate XFEL structure are incidental to or important for
catalysis. Synchrotron X-ray crystallographic data indicate that the G150A mutation
enhances sampling of shifted helical conformations even in the absence of C101
modification, and this shifted conformation is further populated once the C101-Ile152 Hbond is weakened by C101-SOH formation. In addition, G150A ICH accumulates a
spectrally distinct 335 nm species that likely corresponds to the thioimidate intermediate
detected by XFEL crystallography. Our interpretation of these data is that the thioimidate
intermediate accumulates in G150A ICH owing to an impaired resetting of the strained
helical conformation, which reduces the rate of thioimidate hydrolysis and enzyme
turnover. Consistent with the pre-steady state kinetic data, this kinetic model for G150A
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ICH predicts that the early chemical steps promoted by the strained conformation of helix
H would not be impaired by the mutation but that the steady-state rate would be
significantly diminished. In contrast, the G150T mutation causes a constitutively shifted
helix, reducing rates of both initial C101 attack at the isocyanide carbon atom in the first
chemical step and thioimidate hydrolysis in later steps, as evidenced by the lower burst
and steady state rates of G150T ICH. Therefore, the G150A and G150T mutations have
divergent effects on the early steps of ICH catalysis but similar detrimental effects on the
later, rate-limiting steps.
Protein structures fluctuate owing to thermal motion and in response to functional
changes such as ligand binding. As a consequence, it is challenging to determine which
protein motions are functionally most important at equilibrium. Enzymes that are
transiently covalently modified during catalysis offer a way to identify functional
motions, as the modification can trigger catalytically important conformational changes.
The covalent modification of the active-site cysteine in isocyanide hydratase weakens a
critical hydrogen bond required for reactivity. Hydrogen bond disruption triggers a
cascade of conformational changes whose modulation by mutation is detrimental to
enzyme turnover. Most enzymes that form catalytic intermediates will experience similar
transient changes in active-site electrostatics, suggesting that modification-gated
conformational dynamics is common in enzymes. Notably, all cysteine thiolates will
experience a similar loss of negative charge upon covalent bond formation. Because
cysteine residues can have multiple roles in a protein, including catalytic nucleophile,
metal ligand, acylation target, redox target, and others, many different modificationmediated signals may be transduced through altered cysteine electrostatics to impact
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protein dynamics and function, expanding the ways in which cysteine can couple protein
biophysical properties to cellular needs. Integrating recent developments in serial and
conventional RT crystallography with advanced computational methods531 can offer new,
exciting opportunities to reveal enzyme mechanism and interrogate the consequences of
cysteine modification on protein dynamics.
Modulation of protein dynamics is a powerful way to regulate protein function, as
has been characterized in various systems. Cysteine modification-gated conformational
changes in ICH alter the active site environment, promoting progress along the reaction
coordinate. To our knowledge, ICH is the first example of a non-disulfide cysteine
modification regulating functional protein conformational dynamics. Nevertheless,
conceptually similar examples of gated conformational dynamical changes exist. Redoxgated changes in flavoprotein structure and dynamics may play a major role in electron
transfer by these proteins558, and similar electron- or charge-coupled gating events occur
in diverse systems 532,559,560. Photoactivatable tags that modulate sampling of active
enzyme conformations have been used to create catalytically enhanced enzymes192. In the
DJ-1 superfamily to which ICH belongs, C106 oxidation to C106-SO2- in DJ-1 results in
little change in global protein conformation but stabilizes the protein by over 12 °C561.
This stabilization is thought to be due to a strong (2.47 Å) hydrogen bond between C106SO2-and Glu18 that forms upon oxidation, reducing protein dynamics and stabilizing the
protein. The many potential covalent modifications of cysteine make this residue of
particular importance for understanding how cellular signaling states, metabolite pools,
and stress conditions couple to functional protein dynamics through the modification of
amino acids in proteins. Future work on ICH and other cysteine-containing proteins will
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illuminate the diverse mechanisms by which cysteine-gated conformational changes can
regulate protein function.

101

CHAPTER 5:
Purification, Kinetics and Structural Characterization of novel ICH
homolog, RsICH from Ralstonia solanacearum GMI1000.

Note: The results described in this chapter have not been published.

Strained residues (in yellow spheres) cluster near functionally important
regions in the RsICH dimer.
The mobile helices are labeled “A” and “B” near the top of the dimer, and the
active site C121 residues shown in sticks.
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5.1 Abstract:
Isocyanide hydratase (ICH) catalyzes the conversion of isocyanide natural
products to N-formamides by the addition of water. ICHs are widely distributed in
pseudomonad bacteria, where they play a protective role against antimicrobial isocyanide
natural products. We have previously characterized the ICH from Pseudomonas
fluorescens (PfICH) using structural and biophysical approaches. PfICH exhibits
collective motions that are activated by catalysis and permit water access to the catalytic
thioimidate intermediate for hydrolysis. To determine if this dynamical aspect of ICH
was a general feature, we recently determined an ultra-high resolution (0.74Å) X-ray
crystal structure of wildtype ICH from Ralstonia solanacaerum GMI1000 (RsICH). Like
PfICH, RsICH exhibits backbone torsional strain near the active site cysteine residue that
is important for helix motion in PfICH. In addition, RsICH also has an unusually large
amount of side chain strain, including deviations from planarity of multiple residues near
functionally important sites within the enzyme. Our working hypothesis is that foldinduced structural strain in the backbone and sidechains of these residues undergoes
changes during catalysis to support correlated, functional motions. We expect that
geometric stain in RsICH will relax upon intermediate formation and concurrent helix
displacement and then increase as the catalytic cycle is completed. This chapter of the
thesis will include ongoing and planned future work, involving X-ray crystallography,
enzyme kinetics and site directed mutagenesis to determine if conformational strain in
RsICH is important for efficient catalysis. This model for the coupling between enzyme
structure, dynamics, and function may provide general insight into how catalytic cysteine
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covalent modification alters conformational ensembles and non-equilibrium motions in
other cysteine-dependent enzymes.
5.2 Introduction:
Although enzyme catalysis is the central phenomenon of biochemistry, the
relationship between their remarkable catalytic proficiency and structural and dynamical
properties is not fully understood257,562,563. Because enzymes often catalyze complex
reactions with one or more reaction intermediates, directly observing enzyme catalysis in
real time and at atomic resolution has been a foundational goal of structural enzymology.
Technical advances in Xray crystallography now
permit the direct
monitoring of enzyme
turnover in crystalline
samples, including
identifying nonequilibrium enzyme
Figure 1: Clustal W pairwise sequence alignment. RsICH
(WP_011001740.1) shares conserved catalytic residues with PfICH
(3NON) (36% identity).

motions564–566 during
catalysis. These new

technologies allow enzyme motions to be mapped while progressing along the reaction
coordinate, addressing a long-standing challenge of visualizing and identifying
functionally relevant enzyme dynamics. The primary focus of this thesis is cysteinedependent ICH enzymes, which form covalent catalytic intermediates that modify the
structural, electrostatic, and dynamic environment of the active site567,568. Catalysis-
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activated enzyme motions provide a general model to explain how enzymes that use
covalent catalysis are transiently modified to aid substrate turnover. Therefore, what is
learned from ICH will be relevant to a large class of biomedically important enzymes.
The previous chapter (Chapter 4) discussed the formation of a catalytic cysteine (C101)
covalent intermediate (thioimidate) in Pseudomonas ICH (PDB: 3NON). Formation of
this cysteine covalent adduct alters active site electrostatics and induces dynamical
changes that facilitate efficient substrate turnover and enzyme regeneration. To
investigate how common cysteine-modification gated enzyme functional dynamics is, we
identified a distant (36% identity) ICH homolog from Ralstonia solanacaerum GMI100
(NCBI Reference Sequence: WP_011001740.1) (RsICH) (Fig. 1).
5.3 Materials and Methods:
Cloning and Mutagenesis of Ralstonia solanacearum GMI1000 ICH (RsICH): The
RsICH gene was synthesized with E. coli codon optimization from Invitrogen (Thermo
Fisher Scientific) and inserted using Infusion cloning (Takara Bio USA, Inc) between the
NdeI and XhoI restriction sites of the bacterial expression vector pET15b (Novagen,
Darmstadt, Germany) so that the expressed protein carries an N-terminal, thrombincleavable hexa-histidine tag. The final recombinant RsICH protein is 224-amino acid
long with a calculated molecular mass of 24,158 Da. All point mutations (E122Q,
E122D, E122T, C121S) were generated by site-directed mutagenesis using Q5 Site
Directed Mutagenesis (New England Labs) and High-Fidelity Phusion DNA polymerase
(Thermo Fisher Scientific) and appropriate mutagenic primers from Eurofins (Oligo
synthesis). All ICH constructs were verified by DNA sequencing (Eurofins, Genewiz).
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Protein Expression and Purification: E. coli BL21DE3 cells bearing the RsICHpET15b construct were grown in LB medium supplemented with 100 μg/ml ampicillin, at
37 °C with shaking at 250 rpm until the A600 reached 0.5–0.7. Overexpression of ICH was
induced by the addition of 0.66 mM isopropyl β-D-thiogalactopyranoside (IPTG),
followed by 4 h of incubation at 37 °C. Cells were harvested by centrifugation, frozen in
liquid nitrogen, and stored at −80 °C until needed. Frozen cell pellet was thawed on ice
and resuspended in lysis buffer (50 mM HEPES, pH 7.5, 300 mM KCl, 10
mM imidazole). The suspended cells were lysed by the addition of hen egg white
lysozyme (final concentration of 40 mg/ml) at 4 °C for 30 min, followed by sonication (5
second pulse on, 15 seconds pulse off settings) and centrifugation to remove cell debris.
The cleared supernatant (lysate) was applied to a His-select Ni2+ metal affinity column
(Sigma-Aldrich) that had been equilibrated in lysis buffer and bound for 1 hour at 4°C.
The recombinant hexa-histidine tagged RsICH was purified using Ni2+ metal affinity
chromatography using 250 mM imidazole to elute bound protein. The eluted protein was
dialyzed overnight at 4 °C against storage buffer (25 mM HEPES, pH 7.5, 100 mM KCl).
The following day, the hexa-histidine tag used for protein purification was removed by
thrombin cleavage (2 units of thrombin/mg of ICH) at room temperature for 2-3 hrs,
followed by passage over Ni2+ metal affinity resin to remove any uncleaved protein that
retained the histidine tag. Thrombin was removed by passage over benzamidineSepharose resin (GE Healthcare). The eluted protein was then dialyzed overnight at 4 °C
against 25 mM HEPES, pH 7.5, 2mM DTT to remove any salts. The following day the
protein was passed through UnoQ ion exchange chromatography (Bio-Rad). The protein
fractions were pooled together, and protein concentration was determined using a
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calculated extinction coefficient of ϵ280 = 31,065 M−1 cm−1 based on the amino acid
composition of R. solanacearum ICH. The final protein shows up as a ∼24 kDa single
band on overloaded Coomassie Blue-stained 12 % SDS-PAGE. Purified RsICH was
concentrated to 16-27 mg/ml using a centrifugal concentrator (Amicon, Billerica, MA),
supplemented with 2 mM DTT, frozen in liquid nitrogen, and stored at −80 °C. The
E122Q, E122D and E122T mutants were purified following the same protocol.
Crystallization, preliminary X-ray data collection, and processing: All crystals of
RsICH were grown at room temperature using the hanging drop vapor diffusion method.
For wild-type, E122Q, E122D, E122T RsICH, drops containing 2 μl of protein at 16-27
mg/ml and 2 μl of reservoir solution (16% PEG 3350, 0.1M MES, pH 6.5) were
equilibrated against 500 μl of reservoir solution supplemented with 8% Dioxane or 8%
Ethanol. The choice of the additive is significant because 8% dioxane supports plate-like
crystals, while 8% ethanol supports rod like crystals in both wildtype and the mutants.
Both plate type and rod type crystals were determined to be space group P 21 21 21. A
third form of RsICH crystals were grown with 5-15% PEG 400 as additive; they were
tetragonal in space group P 43 12 1.
All the crystals were cryo-protected by passage through six solutions of
incrementally increasing amounts of ethylene glycol to a final concentration of 30% (v/v)
in the reservoir solution. The cryoprotected crystal was cooled by immersion into liquid
nitrogen. Preliminary wildtype and E122 D,Q and T RsICH crystal X-ray diffraction data
at 1.5 Å were collected at the University of Nebraska Macromolecular Structural Core
Facility from single crystals maintained at 110 K using MicroMAX-007 rotating copper
anode X-ray generator (Rigaku/MSC, The Woodlands, TX) operating at 40kV and
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20mA, Osmic Blue confocal optics, and a Raxis IV++ image plate detector. All data
were indexed, scaled, merged and refined using iMosflm, Aimless, Pointless, and
Refmac5 from the CCP4i suite, with final data statistics in Table 5.
RsICH microcrystal growth and fixed-target serial crystallography data collection
and refinement: wt RsICH microcrystals were grown by batch seeding. Initial seeds
were obtained by pulverizing macroscopic rod type crystals via vortexing with 0.5 mm
stainless steel balls for 5-10 minutes. A 1:1500 dilution of this seed stock was added to
26% PEG 3350, 50 mM MES (pH 6.5), 16% Ethanol and 22% Ethylene glycol and then
an equal volume of 38 mg/ml wtRsICH was added and rapidly mixed. The dilution of the
seed stock dictated the final size of the microcrystals and was optimized to produce
crystals measuring ~20x7x7 μm. The mixture was incubated at room temperature with
shaking for ~20 minutes until microcrystal growth stopped. A 1.2 Å resolution serial
crystallography dataset was collected at 100 K from microcrystals on a MiteGen mesh
support using a fixed target strategy at SSRL beamline 12-2. This dataset comprised
~1400 indexed frames with 99.43 (95.62) % completeness, 23.36 (5.90) multiplicity, and
a CC1/2 of 0.93. (0.17) (values for highest resolution shell in parentheses). This is a
remarkably high-quality dataset given the limited number of images and the fact that it
was collected at a synchrotron rather than an XFEL. The future goal is to collect a higher
resolution MISC dataset at an XFEL due to the higher X-ray flux per exposure.
RsICH enzyme kinetics. The substrate used for all the kinetics experiments was para
nitro-phenyl isocyanide (p-NPIC), synthesized by the Berkowitz group (University of
Nebraska Lincoln, Department of Chemistry). Steady state RsICH rate measurements
were initiated by the addition of ICH (final concentration of 0.1 µM) to freshly prepared
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p-NPIC solutions ranging from 0-1000 µM in reaction buffer (100 mM KPO4 pH=7.0, 50
mM KCl, and 20% DMSO, pH 7.6). p-NPIC was diluted from a 0.5 M stock solution in
dimethyl sulfoxide (DMSO), which was stored at -80 °C and protected from light. A 200
µl reaction was maintained at 25 °C in a Peltier-thermostatted cuvette holder. The
formation of the product, para-nitrophenyl formamide (p-NPF) was monitored at its
absorption maximum of 320 nm for two minutes using a UV-Vis Cary 50
Spectrophotometer (Varian, Palo Alto, CA). A linear increase in A320 was verified and
used to calculate initial velocities. The extinction coefficient at 320 nm for p-NPF was
determined by using ICH to convert known concentrations of p-NPIC to p-NPF, followed
by measuring the absorbance at 320 nm. The slope of the resulting standard curve was
defined as the extinction coefficient of p-NPF at 320 nm; ε320=1.33x104 M-1 cm-1. This pNPF ε320 value was used to convert the measured rates from A320/sec to [p-NPF]/sec. All
data were measured in triplicate or greater and mean values and standard deviations were
plotted and fitted using the Michaelis-Menten model as implemented in Prism (GraphPad
Software, San Diego, CA).
Pre-steady state ICH kinetics were measured at 25 ˚C using Hi-Tech KinetAsyst
stopped flow device (TgK Scientific, Bradford-on-Avon, United Kingdom). Data were
collected for each sample for two seconds (instrument deadtime is 20 ms) in triplicates
and product evolution was monitored at 320 nm using a photodiode array detector.
To ensure that the fixed target serial crystallography at SSRL beamline 12-2 was
successful, as a pre-requisite, tests of catalysis were performed on RsICH microcrystals
in the stabilization solution (26% PEG 3350, 50 mM MES (pH 6.5), 16% Ethanol and
22% Ethylene glycol). The crystals were pelleted at 7.5 rpm for 1 minute and then
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resuspended in stabilization solution to remove any free protein. Rate measurements were
performed by the addition of the wt RsICH microcrystals (final concentration of 5-50
µM) to freshly prepared p-NPIC solution at 500 µM in stabilization buffer (26% PEG
3350, 50 mM MES (pH 6.5), 16% Ethanol and 22% Ethylene glycol).Total reaction
volume was maintained at 200 µl at 25 °C in a Peltier-thermostatted cuvette holder. The
formation of the product, para-nitrophenyl formamide (p-NPF) was monitored at its
absorption maximum of 320 nm for five minutes at 20 second intervals using a UV-Vis
Cary 50 Spectrophotometer (Varian, Palo Alto, CA).
Isocyanide (p-NPIC) toxicity assays. E coli BL21DE3 cells bearing the wtRsICH
containing pET15b recombinant plasmids were grown until OD600=0.5-0.6 at 37˚C and
250rpm shaking, upon which they were induced with 0.5mM IPTG. 1 ml of induced cells
were mixed rapidly with 5mls of cooled autoclaved soft agar (0.8%) supplemented with
100mg/ml Ampicillin and poured over 1.5% LB agar plates and incubated at room
temperature (22-25˚C) for 1 hour. Once the soft agar had solidified, stress chemicals
were prepared fresh (500mM, 100mM and 10mM p-NPIC in 100%DMSO). Each LBA
plate was divided into four quadrants and sterile autoclaved filter discs (1 cm diameter)
were placed in the four sections. 10µl stress chemical was added to each disk and the
plates were incubated at 37˚C overnight. Diameters of the developed zone of clearances
were manually measured in triplicates after 24 hours and plotted as a function of substrate
concentration using Prism (GraphPad Software, San Diego, CA). The same protocol was
followed for the mutants E122D, Q and T RsICH.
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5.4 Results:
5.4.1. RsICH is a faster and more potent ICH compared to PfICH.
Like its homolog PfICH, Ralstonia ICH breaks down the isocyanide substrate pNPIC into the corresponding p-N formamide, which can be tracked spectrally at 320nm.
However, RsICH is much faster, with a turnover number of ~ 75 s-1compared to 0.2 s-1 in
PfICH (Fig. 9.A) (Tables 1,4). Pre-steady state kinetics of RsICH indicates an absence of
a burst phase that is present with PfICH (Fig. 9 D-C). This indicates that the process of
thioimidate hydrolysis and

Figure 2: (A). Impaired steady state Michelis Menten kinetics of (clockwise from left) wt,
E122D, Q, T RsICH. (B). E. coli BL21DE3 p-NPIC toxicity assay reveals in vivo effects of
impaired catalysis in E122 mutants. (C). Disk diffusion assay showing zones of inhibited E.
coli growth near disks impregnated with the indicated concentrations (mM) of p-NPIC. (D).
PfICH shows burst phase in stopped flow mixing experiment. (E). RfICH exhibits no burst
phase, indicating faster rates of thioimidate formation/hydrolysis
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product formation in RsICH must occur faster than in PfICH and the rates of formation
and hydrolysis are more closely matched or that the rate-limiting step in RsICH is now
thioimidate formation. It is possible that RsICH also has a burst phase that is within the
~20 ms dead time of the instrument, although this seems unlikely. To test this hypothesis,
we could perform the stopped flow experiment in a reaction buffer in which RsICH is
slower to lengthen the pre steady-state rate. One potential way to do this is by optimizing
the reaction buffer composition. We have measured catalytic turnover in microcrystals of
RsICH in the crystallization buffer (16% PEG 3350, 0.5M MES/Citrate pH 6.5, 8%
ethanol) (Fig. 6.B) (More details in section 5.4.4). The rate of turnover can be controlled
by changing the relative concentrations of the MES or citrate buffers (both at pH 6.5) in
the crystal (Fig. 6.D). MES decreases in crystallo reaction rates because it is loosely
bound at a site that partially occludes a solvent channel to the active site in the 0.74 Å
resolution crystal structure (Fig. 6.C). Although these experiments have not been
conducted with the enzyme in solution, it will be worth investigating if tuning the MES:
citrate ratio in the reaction buffer sufficiently slows down RsICH in solution catalysis to
observe the intermediate formation/hydrolysis step. Another possible method would be to
employ single-turnover kinetics, which would allow further isolation of the first catalytic
turnover of the enzyme
5.4.2. E122 D, Q and T mutations in the RsICH active site significantly impairs
catalysis. E122 residue, immediately following the reactive C121, was mutated to a
Threonine (E122T) to simulate the active site environment of the Pseudomonas ICH, to
investigate the contribution of E122 to the faster rates of catalysis in RsICH. E122D
mutant was generated to investigate the potential steric effects of E122 within the active
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site, and finally, the E122Q mutant was made to disrupt the hydrogen bonding
environment within the active site. The E122 D, Q, T mutants exhibit impaired steady
state kinetics (Fig.2.A) (Table 4) with turnover numbers ~ 0.2 s-1, 0.4 s-1 and 0.3 s1

respectively. p-NPIC toxicity assays performed on E. coli BL21DE3 cells bearing the

wildtype RsICH construct show that these cells tolerate isocyanide much better than E.
coli cells expressing PfICH (Fig. 2. B-C). The E122D, Q and T RsICH mutations,
however, diminish isocyanide tolerance levels to

Figure 3: (A-B). 0.74 Å dataset of RsICH. 2Fo-Fc electron density (blue 1.0σ) and Fo-Fc difference
density (green +3σ, red -3σ) show deprotonated bond lengths of E122 (1.24-1.25 Å) and 3.48 Å
hydrogen bond with C121 thiolate. (C) conserved C147-C220 disulfide bond in RsICH (2.08 Å).

comparable with wt and G150A and G150T PfICH (Fig. 5, Chapter 4).
Although the E122 mutation seems to significantly impair catalysis, it is not yet
obvious why. Neither is it clear why RsICH is a faster ICH than PfICH. In the
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Pseudomonas ICH, the reactive C101 (PfICH numbering) is immediately followed by a
T102, while in Ralstonia ICH it is a Glu122 (RsICH numbering). Moreover, ultra-high
resolution (0.74-0.9 Å) resolution dataset(s) of RsICH crystals reveal that E122 is
deprotonated (hence negatively charged) with a Cδ-Oε1/2 bond lengths of ~1.25 Å
(Fig.10. A) (Data statistics in Table 6). Surprisingly, this ionized carboxylate is 3.48 Å
away from the reactive C121 (RsICH numbering) in wt and E122D, Q, T RsICH. We
know that for the catalytic reaction to occur, C121 must be a nucleophile, thus
deprotonated to the thiolate. It is unclear how these two negatively charged neighboring
residues (E122, C121) would stably exist so near to one another in the active site440
(Fig.10. A-B). It is important to note here that a protein BLAST revealed several ICH
homologs with a glutamic acid following the nucleophilic Cys; however it remains to be
examined whether these glutamic acids are also deprotonated as seen in RsICH.
It is possible that the negatively charged electrostatic environment created by both
C121 and E122 interacts with the formal positive charge on the nitrogen atom of the
isocyanide substrate and helps position the substrate for attack in the active site of the
enzyme. In this case, RsICH has greater potential for electrostatically pre-organizing the
Michaelis complex than the slower PfICH, which has a threonine (T102) (Pseudomonas
numbering) at this position. It is also possible that the strong negative charge created by
these two residues in RsICH electrostatically strains the active site prior to catalysis, and
that formation of the thioimidate neutralizes the negative charge of C121 relieves this
electrostatic strain and stabilizes the Michaelis complex. The restoration of the thiolate
upon hydrolysis of the thioimidate may restore electrostatic strain that facilitates product
release. Another hypothesis is that C121 is initially protonated as a thiol and binding of
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the substrate p-NPIC leads to its ionization; the deprotonated C121 nucleophile then
attacks the electrophilic isocyanide carbon and initiates the reaction. Additional
experimental work is required to experimentally test these hypotheses. It would be
interesting to see if making a T102E mutation in PfICH (PfICH numbering) speeds up the
reaction to similar rates as seen in RsICH.
Another unusual structural feature observed in RsICH is the existence of a
conserved disulfide bond between two of its cysteines (C147 and C220) near the Cterminus of the enzyme (Fig.10. C), even though RsICH must folded in the reducing
E.coli cytosol during recombinant protein expression573,574 . The high degree of
conservation of the cysteine residues in this bond, as well as its robustness to DTT
(1mM) to prevent oxidation during protein purification both suggest possible functional
importance. Because disulfide bonds are typically formed and maintained within an
oxidizing environment like the endoplasmic reticulum in eukaryotes574, one possibility is
that the C147-C220 disulfide bond is formed in the more oxidizing E.coli periplasm 422.
However, proteins are targeted into the periplasm by specific signal sequences575,575–577
and it remains to be explored whether RsICH is targeted in a similar manner.
5.4.3. RsICH exhibits cysteine-gated active site helix dynamics similar to PfICH.
We have obtained a 1.5 Å resolution rotating anode crystal structure of RsICH at pH 5.5
(Table 5). This lower pH structure shows clear evidence of crystallographic disorder near
the highly strained Ramachandran outlier I175 (corresponding to I152 in Pseudomonas
ICH), indicating

115

Figure 4: (A). Ralstonia ICH shows mobility near the active site at pH 5.5. 2Fo-Fc electron
density (blue 1.0σ) and Fo-Fc difference density (green +3σ, red -3σ) show clear evidence of two
conformations of the active site C121 (A, B) and mobility of the strained I175 in the mobile helix.
(B) No evidence of helix mobility in Ralstonia ICH pH 6.5. 2Fo-Fc electron density (blue 1.0σ)
and Fo-Fc difference density (green +3σ, red -3σ).

helical mobility (Fig. 4). We observe this disorder at pH 5.5 and not in the 0.74 Å
resolution structure at pH 6.5 likely because the active site cysteine is protonated at 5.5,
neutralizing its charge and weakening the H-bond with I175. This is the same chargegated H-bond mechanism that we propose for Pseudomonas ICH in chapter 4.
5.4.4. Identification of side chain geometric strain in the ultrahigh resolution crystal
structure of RsICH.

Figure 5: (A) 2Fo-Fc electron density (blue 1.0σ; purple 4.5σ) at 0.74 Å resolution for W85 shows the
exceptional quality of the data. The protrusions at in the 2Fo-Fc electron density are hydrogen atoms. (B)
Side view of W85 shows obvious deviations from planarity. (C) Strained residues (in yellow spheres)
cluster near functionally important egions in the Ralstonia ICH dimer; the mobile helices are labeled “A”
and “B” near the top of the dimer, and the active site C121 residues shown in sticks.
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We have recently collected a synchrotron X-ray diffraction dataset of Ralstonia ICH
(RsICH) at 100 K to 0.74 Å resolution (Table 6). This ultrahigh resolution dataset allows
the well-ordered parts of the structure to be refined with no influence from geometric
restraints, as the observation-to-parameter ratio for unrestrained refinement is ~13. Even
when restraints are maintained, residues Y15, W37, W85, R162, Y163, and Y204 all
exhibit pronounced planarity deviations. W85 in particularly is extremely distorted, with
a clearly nonplanar indole ring (Fig. 5). In Ralstonia ICH (RsICH), most of the strained
residues cluster near the active site or surround the helix that is mobile during catalysis in
Pseudomonas ICH (PfICH). It is possible that this conformational strain in RsICH
facilitates important conformational changes in the enzyme during catalysis, and as such,
we strongly suspect a connection between these strained residues and RsICH catalysis.
5.4.5. Future work will include tracking the origin and dynamics of conformational
strain in RsICH during catalysis using MISC.
Future work will involve the use of computational methods to identify the origin
of the strain in the mentioned residues, allowing us to determine the physical origin of
these effects, including the energetics of distortion and the major structural determinants
of these deviations. Building from the computational results, we will mutate those
residues identified as distorting the strained sidechains in order to reduce or eliminate
strain. We will determine crystal structures of these designed mutants to validate the
effects on geometric strain and then compare computationally predicted and observed
sidechain geometries. Using these strain-modulating mutants, we will then perform
steady and pre steady-state kinetic analysis using p-NPIC as substrate. By combining
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computational, structural, and kinetics approaches, we will be able to determine the
contribution of sidechain strain to Ralstonia ICH (RsICH) catalytic proficiency.
We will also perform accurate measurement of the geometric strain in the nonplanar residues in RsICH. For this, we will need atomic resolution (≤1.2 Å) data for
Ralstonia ICH, which will be the highest resolution MISC dataset ever collected.
Preliminarily, we have established the feasibility of this experiment by reliably growing
microcrystals (~20x7x7 μm) (Fig. 6.A) and collecting a 1.2 Å resolution serial
crystallography dataset from a fixed target mesh at SSRL beamline 12-2 (Methods).
These high-resolution time-resolved data will be used to investigate the changes in
geometric strain that we hypothesize may facilitate motions that are important for
turnover. This could potentially be the first experiment in which conformational strain
will be directly observed in an enzyme during catalysis. To establish feasibility of the
planned MISC component of the experiment, we measured catalytic turnover in
microcrystals of Ralstonia ICH in the crystallization buffer (16% PEG 3350, 0.5M
MES/Citrate pH 6.5, 8% ethanol) (Fig. 6.B). The rate of turnover can be tuned by
changing the relative concentrations of the MES or citrate buffers (both at pH 6.5) in the
crystal (Fig. 6.D). MES decreases in crystallo reaction rates because it is loosely bound at
a site that partially occludes a solvent channel to the active site in the 0.74 Å resolution
crystal structure (Fig. 6.C).
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Figure 6: (A) RsICH microcrystals. (B) Ralstonia ICH microcrystals are catalytically active.
Spectra were collected every 20 s, from purple to red. The product absorbs at 320 nm. (C) MES
bound in the active site of RsICH. 2Fo-Fc electron density (blue 1.0σ) and Fo-Fc difference density
(green +3σ, red -3σ) (D) Rates of microcrystal catalysis can be altered by manipulating the Citrate:
MES (pH 6.5) ratio in crystallization buffer.

We expect that Ralstonia ICH will exhibit catalysis-gated motions that are coupled to
intermediate hydrolysis, with geometric strain relaxing during intermediate
formation/helix displacement and then increasing again as the catalytic cycle is
completed. Importantly, the atomic resolution of the data will make this a first-of-kind
MISC experiment, and the resulting data will allow the development of improved tools
for all steps in the serial crystallography data processing and model refinement workflow
that will benefit the structural biology community.
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5.5 Discussions:
Preliminary kinetics and in vivo toxicity assays show that Ralstonia ICH (RsICH)
is a faster ICH enzyme compared to its Pseudomonas (PfICH) homolog. Moreover,
RsICH diffracts to ultra-high resolution (0.74 Å) and diffracts to atomic resolution (≤1.2
Å) in a serial crystallography experiment. There are only about a dozen ultra-high
resolution datasets (≤0.07 Å) in existence 582. Interestingly, the 0.74Å RsICH dataset
shows fold-induced backbone and sidechain strain. Particularly, amino acid residues
Y15, W37, W85, R162, Y163, and Y204 all exhibit pronounced planarity deviations,
which is highly unexpected. Other ultrahigh resolution datasets also exhibit aromatic
planarity deviations, and these strained residues are typically in functionally important
parts of those structures569–572. In RsICH, most of the strained residues cluster near the
active site or surround the helix that is mobile during catalysis in PfICH, strongly
suggesting a connection to ICH function, which remains to be explored.
Because of the exceptional resolution of the preliminary synchrotron X-ray
dataset (0.74 Å), these deviations from planarity are well-determined by the data and thus
residue geometry is confidently known. Similar geometric strain has been observed in
other proteins that diffract to ultrahigh resolution583,584, but its origin is unknown. Future
work will include determination of the origin of this strain and investigate how catalytic
modification of the active site couples to strained residues throughout the protein to
activate functional motions. The proposed work will elucidate general physical
mechanisms by which cysteine modification alters protein structure and function, with
potentially wide applicability to other biomedical important proteins, including the
development of small molecules that covalently target key cysteine residues.
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